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FOREWORD
This dissertation is composed of three chapters tha t investigate the 
interaction of cigarette smoke with tw o proteins: o-1-proteinase inhibitor and 
ferritin. The main purpose in this investigation is to  elucidate possible 
mechanisms by which cigarette smoking causes a number of pathological 
conditions, principally pulmonary diseases.
The first chapter, "Inactivation of alpha-1-proteinase Inhibitor by Ciga­
rette Smoke", will be submitted for publication to  Biochemical and 
Biophysical Research Communications. This chapter reports on studies done 
on the mechanism(s) of inactivation of a -1-proteinase inhibitor by cigarette 
smoke.
The second chapter, "Peroxynitrite Inactivates a -1-proteinase Inhibitor 
by Oxidation of Methionine", will be submitted for publication to Chemical 
Research in Toxicology. This chapter investigates the mechanism of 
inactivation of a -1-proteinase inhibitor by peroxynitrite and its connection 
with the  pathogenesis of emphysema.
Finally, chapter three, "Release of Iron from Ferritin by Aqueous 
Solutions of Cigarette Smoke", w as authored by Juan  J . Moreno, Mahtab 
Faroozesh, Daniel F. Church and William A. Pryor. The manuscript has been 
submitted for publication to Chemical Research in Toxicology on May 1991. 
This chapter reports on the ability of cigarette smoke solutions to  release
iron from ferritin and on the identification of possible species in cigarette 
smoke responsible for the reduction and release of iron from ferritin.
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ABSTRACT
We have studied the interaction of cigarette smoke with two proteins: 
alpha-1-proteinase inhibitor (a1PI) and ferritin. The inactivation of o r l P I ,  the 
major plasma inhibitor of serine proteases, by cigarette smoke has been 
implicated in the etiology of pulmonary emphysema. Release of iron from 
ferritin, the principal source of physiological iron, by cigarette smoke could 
explain increased amounts of iron observed in the pulmonary alveolar 
macrophages of smokers.
These studies show  that cigarette smoke reacts with proteins to 
cause amino acid modifications by two mechanisms: oxidation of methionine 
and nonoxidative modification of the basic amino acids. Modifications of 
methionine and lysine result in impairment of the elastase inhibitory activity 
of a1PI. We have indirectly shown that hydrogen peroxide, formed during 
the autoxidation of hydroquinones found in smoke, could contribute to 
oxidation of methionine. Modification of Lys residues could arise from their 
reaction with formaldehyde and cyanide found in cigarette smoke. Using 
NMR analysis, we have tentatively identified N-e-cyanomethyl lysine as the 
product of the reaction of a synthetic peptide, containing the amino acid 
sequence of the active site of a1PI, with cigarette smoke.
Peroxonitrite could be formed from the reaction of nitric oxide and 
superoxide in aqueous solutions of smoke. Kinetic studies show  this
xvi
peroxide decomposes with a half-life of 4 .6  s at physiological pH, and 
rapidly inactivates a1PI in a dose-dependent manner, suggesting that 
peroxonitrite is one species responsible for the smoke-induced inactivation of 
o1PI. Our results also indicate that peroxonitrite is a powerful oxidant, 
capable of oxidizing methionine residues in proteins without the involvement 
of hy/droxyl radicals or nitrogen dioxide.
Solutions of cigarette smoke induce iron release from ferritin. Under 
anaerobic conditions, faster rates of iron release are observed and the 
reducing power of cigarette smoke solutions is prolonged. The 
concentrations of hydroquinone and catechol in cigarette smoke solutions 
increase as the smoke is subjected to less filtration. Their increase 
correlates with higher rates of iron release. These observations indicate that 
cigarette smoke could release iron from ferritin and alter iron metabolism, 
increasing the oxidative burden in the lungs of smokers.
INTRODUCTION
Cigarette Smoke Overview. Cigarette smoke is an enormously 
complex chemical system; about 4000  compounds have been identified (1) 
in smoke, and this number is constantly increasing as new and more 
sensitive techniques are developed. Smoke is formed from the incomplete 
combustion of tobacco and leads to the formation of two types of smoke: 
mainstream and sidestream (2). Mainstream smoke (MS) is defined as the 
smoke generated in the burning cone and in other hot zones of the cigarette 
during puff-drawing which, after travelling through the tobacco column, 
comes out at the mouthpiece. Sidestream smoke is generated between 
puffs as the cigarette smolders, and is emitted into the ambient air. The 
data presented throughout this dissertation was obtained utilizing 
mainstream smoke generated from reference cigarettes and using 
standardized smoking parameters (3). The reference cigarettes used (1R1, 
1R4F, and 2R1F) are considered international standards for research 
purposes and have been approved by representatives of commercial 
manufacturers and by the Tobacco and Health Research Institute (4). For 
scientists involved in the numerous aspects of smoke research, the use of 
standard cigarettes provides a common basis for comparison of data.
Of all the effluents of smoke1, about 30%  originates from the
’ Unless otherwise indicated, "smoke" refers to mainstream cigarette smoke.
1
tobacco  and the remainder com es from air drawn through the porous paper 
(1). About 500  mg of smoke is obtained from a nonfiltered cigarette (whole 
smoke) with approximately 83%  of the total weight accounted for by 
nitrogen, oxygen, and carbon dioxide. About 8% is comprised of particulate 
matter, and 3-4%  is carbon monoxide. The remaining 6% of the  m ass is 
composed of inorganic and organic vapor phase constituents (1). Table I 
presents estim ates of the number of constituents identified in the  major 
c lasses of compounds found in cigarette smoke.
By convention the cigarette smoke industry separa tes whole smoke 
into gas phase, particulate phase and tar. Gas-phase is defined as the 
portion of whole smoke tha t passes  through a Cambridge filter, a glass-fiber 
filter capable of retaining 99 .9%  of all particles with diameters of 0 .2  //m or 
larger (5). The particulate phase is defined as all the matter retained in the 
Cambridge filter and tar as the portion of this material minus the weights of 
nicotine and water.
Cigarette Smoke Chemistry. Although the presence of free radicals in 
cigarette smoke w as first observed at the beginning of 1960 (6,7), w e have 
learned more about their mechanisms of formation, structures, and chemical 
reactivities in the past fifteen years through the work of Pryor et al. (8-16).
Cigarette smoke contains two classes of free radicals, one found in tar 
and the  other in the  gas phase (17). The tar radical is exceptionally stable, 
allowing direct observation by electron spin resonance (ESR) spectroscopy.
TABLE I. Estimates of Constituents of Cigarette Smoke*.
Major Classes of Compounds No.
Amides, imides, lactones 240
Carboxylic acids, anhydrides 240
Lactones 150
Esters 475
Aldehydes 110
Ketones 520
Alcohols 380
Phenols 285
Amines 200
N-Nitrosamines 22
N-Heterocyclics 920
Hydrocarbons 755
Nitrites 105
Carbohydrates 45
Ethers 310
TOTALb 4865
a From reference (1).
b About 3 9 0 0  compounds are known; some compounds contain several 
functional groups (1).
This radical has been identified as a quinone-hydroquinone complex (Q/QH2) 
held in a low-molecular weight, tarry matrix (13). The identification of this 
tar radical as a quinone-hydroquinone complex is corroborated by the high 
concentrations of quinones and hydroquinones found in cigarette tar 
(1,18,19). This Q/QH2 radical can reduce dioxygen to form the superoxide 
ion which in turn dism utates to  hydrogen peroxide, known to  form in 
aqueous solutions of cigarette smoke (20-22). Tar also chelates metals such 
as iron or copper which can catalyze the decomposition of hydrogen 
peroxide to form hydroxyl radicals (23). Such tar solutions have been 
show n to cause  single-strand breaks in DNA (24) impeding its synthesis 
(25).
In contrast, the radicals in gas-phase smoke are much lower in 
concentration and less stable than the tar radicals (12); consequently, ESR 
spin trapping techniques have been used for their detection (8). Pryor et al. 
(8,12,16) identified the radicals in gas-phase smoke as consisting of 
inorganic radicals such as nitric oxide (NO) and nitrogen dioxide (N02), as 
well as small carbon- and oxygen-centered organic radicals. The apparent 
half-life of these  gas-phase radicals is found to  be about 5 minutes (8,12) 
which is inconsistent with their known stabilities. This inconsistency has 
been resolved by proposing a steady sta te  mechanism by which the organic 
radicals in gas-phase smoke are continuously being formed as well as 
destroyed (16); this mechanism is shown in equations 1 through 5. Also, in
5support of this mechanism  proposed by Pryor et a/., w e p resen t in Table II 
the  major constituen ts  identified in gas-phase cigarette sm oke.
Nitric oxide (NO) is slowly oxidized to N 0 2 (Eq. 1). NQ2 then  reacts 
with an olefin such as isoprene, via allylic hydrogen abstraction (Eq. 2) or 
addition (Eq. 3), to  give carbon centered radicals (R‘). T hese carbon- 
centered radicals could then be scavenged by oxygen (Eq. 4) to form peroxyl 
radicals (ROO*). Due to  the  high concentration of NO in th e  gas-phase, 
these  peroxyl radicals are expected  to  react with NO (Eq. 5) to give N 0 2 and 
an alkoxyl radical (R 0‘).
NO + 0 2 ---------------> N02 (1)
N02 + RH -------------=> HONO + R* (2)
N02
R* + 0 2  > ROO* (4)
ROO* + NO ■» RO* + N02 (5)
6TABLE II. Major Constituents of the Gas Phase of Cigarette Smoke*.
Type Compound Cone./Cigarette
Inorganic Gases oxygen 67 mg
carbon monoxide 10-23 mg
hydrogen cyanide 30 0  fjg
nitrogen oxides 50-600 fjg
ammonia 50-170 ug
Aldehydes acetaldehyde 0 .5-1 .2  mg
formaldehyde 100 fjg
acrolein 50-100  fjg
Ketones acetone 3 50  fjg
Alkenes isoprene 4 0 0  fjg
ethylene 160 fjg
Aromatic Hydrocarbons benzene 20-50 fjg
toluene 80 fjg
Organic Halides methyl chloride 160 fjg
vinyl chloride 1-25 fjg
Others hydrazine 24-43 ng
urethane 20-38 ng
2-nitropropane 0 .2-2 .2  fjg
methyl nitrate 500  ng
water 6 mg
* This table w as composed from data reported mainly in tw o articles (1,19). 
Although nitrogen and carbon dioxide are tw o of the major com ponents of 
the  gas phase of cigarette smoke, they are not included in this table. In 
addition to the compounds listed, there are about 400-450  minor 
constituents present in gas-phase smoke.
Gas-phase cigarette smoke is considered a highly oxidizing mixture 
and is believed to  place an oxidative burden in the lungs of smokers.
Emphysema and Other Cigarette Smoke Related Diseases. Significant 
evidence implicates cigarette smoking in a number of pathological 
conditions. The three major disorders associated with cigarette smoke are 
cardiovascular disease, cancer and chronic obstructive pulmonary disease 
(18).
Four major categories of cardiovascular disease are believed to be 
accelerated or adversely influenced by cigarette smoke; these  are cardiac, 
disorders of the peripheral circulation, stroke, and venous thrombosis (26). 
The chronic, high levels of carbon monoxide to which cigarette smokers are 
exposed cause arterial wall injury and alterations in lipid metabolism leading 
to hypercholesterolemia (27).
Numerous epidemiological studies have demonstrated higher lung 
cancer mortality ratios for cigarette smokers than for nonsmokers (18). Oral 
cancer and cancer of the larynx, esophagus, bladder, kidney and pancreas 
are also causally related to cigarette smoking (1). The majority of the 
genotoxic and carcinogenic agents identified in cigarette smoke reside 
primarily in the particulate phase (1). The most potent carcinogenic fraction 
of the particulate phase has been show n to be mainly composed of 
polynuclear aromatic hydrocarbons. This fraction only leads to tumor 
induction in the presence of cocarcinogens such as catechols, the major
cocarcinogens of the phenolic portion (28). As mentioned above, cigarette 
smoke has also been show n to  form 8-hydroxydeoxyguanosine (29), to 
induce single-strand breaks in DNA (21,30) and to block DNA synthesis 
(25). Furthermore, cigarette smoke produces hydrogen peroxide (20-22), 
superoxide and hydroxyl radicals (23), all believed to  be implicated in 
carcinogenesis.
The suppression of antiprotease activity in the lung by cigarette 
smoke is probably the most widely accepted explanation for the 
pathogenesis of pulmonary emphysem a (31-34). Alpha-1-proteinase 
inhibitor (a1PI) is the major serum antiproteinase in humans (35), providing 
m ost of the protection against elastolytic activity in the lower respiratory 
trac t (36). Therefore, it is believed that when the antiproteinase/proteinase 
activity ratio is decreased (more proteinase activity), destruction of the 
alveolar integrity occurs (32,37). The validity of this hypothesis has been 
amply corroborated by studies using bronchoalveolar lavage fluids (BAL) 
(32,37-39).
Alpha-1-proteinase inhibitor loses its e lastase inhibitory capacity (EIC) 
upon oxidation of a methionine residue present in the  active site (40-42). 
Carp et a/. (43) determined the presence of methionine sulfoxide in o1PI 
recovered from BAL of cigarette smokers. Methionine sulfoxide, found in 
the inhibitor isolated from BAL of smokers, could result from the interaction 
of <71 PI with phagocytic cells, such as neutrophils and macrophages, as well
9as from direct reaction with cigarette com ponents (14 ,24,44-56).
In spite of the plethora of evidence tha t associates cigarette smoking 
with the pathogenesis of emphysema, the mechanism(s) by which smoke 
causes disease is(are) still not well established or understood.
Purpose of this Investigation. The research group of Dr. W. A. Pryor 
has been interested for some time in elucidating the  mechanism(s) by which 
cigarette smoke causes pulmonary diseases. As part of this continuing 
effort, we have studied the mechanism of inactivation of human alpha-1 - 
proteinase inhibitor, the principal inhibitor against proteolytic degradation of 
lung tissue, by cigarette smoke. Although it had been extensively shown 
that exposure of alpha-1-proteinase inhibitor to  cigarette smoke resulted in 
the inactivation of the protein (14,24,48-56), little w as  known about the 
type of damage sustained by the protein and the identity of the species 
responsible for the loss of activity.
We have also widened the scope of the existing research by studying 
the  interaction of cigarette smoke with ferritin, this protein being the 
principal source of physiological iron. This line of research w as initiated in 
an effort to shed light on the causes of accumulation of iron deposits 
observed in the pulmonary alveolar m acrophages of chronic smokers (57).
Iron is known to catalyze the formation of reactive oxygen species (58) 
which have been implicated in a variety of deleterious oxidative processes 
(59).
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It is possible that the elucidation of the mechanisms by which 
cigarette smoke is believed to cause a variety of diseases could eventually 
contribute to  the development of adequate preventive medicine against 
cigarette smoke toxicity.
CHAPTER I. Inactivation of Alpha-1-Proteinase Inhibitor by Cigarette Smoke
11
INTRODUCTION
12
A significant amount of evidence indicates that cigarette smoking is 
the major risk factor in the development of pulmonary emphysema (60).
The inactivation of alpha-1-proteinase inhibitor (o1PI) by cigarette smoke is 
believed to be a key factor in the etiology of emphysema (31,61). 
Inactivation of o1PI causes an excess  of free protease activity, mainly that 
of neutrophil e lastase (62), in lung tissue, giving rise to emphysema (61). It 
is well established that cigarette smoke inactivates crlPI (24 ,51 ,53 ,56). The 
active site of the inhibitor contains a Met-Ser peptide bond which represents 
the primary binding site for a variety of proteinases such as elastase and 
trypsin (40,48). Oxidation of this key methionine residue has been show n to 
result in the loss of elastase inhibitory capacity (EIC) (40,48). Furthermore, 
a mutated form of crIPI, containing Val in place of Met in the active site, is 
more resistant tow ards oxidants (63) and smoke-induced inactivation (41).
In view of these  observations, it has often been assumed tha t  oxidation of 
Met represents the major pathw ay by which cigarette smoke inactivates 
orlPI (24 ,51 ,53 ,56).
In spite of much speculation, it has not yet been shown, to  our 
knowledge, that cigarette smoke contributes to the etiology of emphysema 
by oxidizing methionine. However, it has been found that a1PI recovered 
from the lungs of cigarette smokers contains 40%  lower EIC than crIPI
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recovered from the lungs of nonsmokers (64) and that the inhibitor isolated 
from smokers contains 4  mol methionine sulfoxide per mol inactive protein, 
while the nonsmokers inhibitor contains no oxidized methionine (43). 
Although relevant, these  findings do not dem onstrate  that cigarette smoke 
could directly oxidize methionine residues in proteins. Methionine sulfoxide, 
found in o1 PI isolated from lung fluids of smokers, could result from the 
action of inflammatory cells present in increased concentrations in the lungs 
of smokers (45,65,66).
We also studied the possibility of cigarette smoke damaging o1PI by 
mechanisms other than oxidation of Met. We find that cigarette smoke not 
only oxidizes Met, but also causes depletions of His and Lys. It had already 
been shown (67,68) that acylation of Lys results in loss of EIC. Concurrent 
with our findings, tw o laboratories published results confirming our 
observations. Gan and Ansari (69,70) reported tha t aldehydes found in 
smoke inactivate a1PI, and Yu et al. (71,72) identified cyanomethyl 
derivatives of Lys formed from the reaction with formaldehyde and cyanide, 
both found in cigarette smoke. Although histidine residues in orlPI have 
been modified by reactions with aldehydes (69) and ozone (73,74), the 
literature does not indicate a loss of EIC as a consequence of such 
modifications.
We here present data obtained from studies of the dam age sustained 
by d P I  during its inactivation by cigarette smoke. In an effort to determine
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the mechanism of inactivation, we also studied the reaction of a synthetic 
peptide (MER10), containing the  amino acid sequence  of the active site of 
o1PI, with cigarette smoke and three of its major components: 
hydroquinone, catechol and formaldehyde (1 ,18 ,19 ,75 ,76).
EXPERIMENTAL
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Chemicals. Human a1PI and porcine pancreatic elastase (EC 
3 .4 .21 .36 ) were purchased from Calbiochem Co. (San Diego, CA). 
N-succinyl-(L-ALA)3-p-nitroanilide (SANA) w as purchased from Sigma 
Chemical Co. (St. Louis, MO). Chelex-100® resin w as purchased from Bio- 
Rad Laboratories (Richmond,CA). Research cigarettes (1R1 and 1R4F) were 
purchased from the University of Kentucky, Tobacco and Health Research 
Institute. The cigarettes were stored at -2 0 °C and humidified in a 
desiccator over saturated ammonium nitrate at room tem perature for at least 
24  hr prior to  use. All other chemicals were of reagent grade and used 
without further purification. Unless otherwise indicated 0.1 M sodium 
phosphate (pH 7.4) pretreated with Chelex-100® w as used as buffer.
Synthesis of Decapeptide. The synthesis of MER10 (Pro-Met-Ser-lle- 
Pro-Pro-Glu-Val-Lys-Phe) w as carried out using a Milligen/Biosearch SAM 2 
automatic protein synthesizer apparatus (Milligen/Biosearch, San Rafael,
CA). Using fe/?-butyloxycarbonyl (t-Boc) as the alpha-amino group 
protecting group, and starting from the C-terminal amino acid which is 
attached to a copoly(styrene-1 %-divinylbenzene) chloromethyl resin, the 
synthesis cycle consisted of deprotection, base washing, coupling and 
capping. The crude product of this reaction was passed through a Sephadex 
G25 column, and further purified by HPLC as described below. This peptide
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contains the amino acid sequence of the inhibitory active site of a1PI from 
Pro357 to Phe366 (40). The elastase inhibitory capacity (EIC) of this synthetic 
peptide w as tested  as described below and found not to be an inhibitor of 
porcine pancreatic elastase.
Smoke Preparation and Exposures. The smoking protocol consisted of 
drawing 35 mL puffs at one minute intervals into a glass syringe fitted with 
a three-way stopcock. The smoke of one cigarette (ten 35 mL puffs) w as 
bubbled through the reaction vessel which w as kept in an ice-bath. For 
direct exposures, the reaction vessel contained 125 fig of a1PI in 1 mL final 
volume of phosphate buffer. For indirect exposures, the vessel contained 
only buffer, and 125 fig of cr1 PI w as added after allowing the smoke solution 
to age at 37  °C for different periods of time as indicated in the pertinent 
figure legends. Unless otherwise indicated, all solutions were incubated for 
24  hours at 37 °C until assayed for elastase inhibitory capacity.
Exposures of MER10 to cigarette smoke were carried out using the 
protocol for indirect exposure unless otherwise indicated. Usually 20  mg of 
peptide (final MER10 concentration w as 35 mM) w as added to 0 .5  mL of 
freshly prepared cigarette solution in buffer. Smoke solutions (gas-phase or 
filtered) used for reactions with MER10 were prepared with the smoke 
collected from three cigarettes.
Gas-phase cigarette smoke refers to the smoke obtained from 1R1 
cigarettes tha t passes through a glass fibre Cambridge filter. Cambridge
filters retain 99 .9%  of all particles with diameters larger than 0.1 pm  (5). 
Filtered-smoke refers to the smoke obtained from 1R4F research cigarettes 
which has been filtered only by the filter tip that these  cigarettes contain. 
Although gas-phase smoke, due to its relatively simple composition, is 
convenient for studies on the toxicity of cigarette smoke, it is not a very 
faithful representation of the smoke delivered by most commercial brand 
cigarettes. Gas-phase smoke, as stated  above, has been subjected to very 
efficient filtration while commercial cigarettes contain either no filter or a 
filter which does not retain particulate matter as  efficiently as Cambridge 
filters. A better model for the smoke to which tobacco users are exposed is 
obtained from 1R4F research cigarettes. This cigarette is equivalent to  a 
low tar commercial cigarette. 1R4F cigarettes deliver approximately 11 mg 
of total particulate matter, 9 .2  mg of tar, and 0 .8  mg of nicotine (4).
For the reaction of MER10 with hydroquinone (1,4-benzenediol) and 
catechol (1,2-benzenediol), 150 pL of a 250  mM solution in each of the 
benzenediols (75 mM final concentrations) was added to 350  pL of MER10 
(35 mM) to give a final volume of 500  pL in buffer. The reaction mixture 
w as incubated for 12 hours at 37  °C in the dark.
Elastase Inhibition Assay. Assays for inhibitory activity were 
performed by measuring the decrease  in elastase enzymatic activity resulting 
from preincubation for 5 minutes at 25 °C with native or smoke-exposed 
o1PI. The EIC of native o1PI w as always taken as 100% . Elastase activity
w as determined according to the  method of Bieth et at. (77). Briefly, in 
952  pL of 0 .2  Tris buffer (pH 8.0), 10 pL of e lastase (0 .14 U/mL) is 
incubated with 30  pL of a  1PI (3.75 //g/mL) for 5 minutes at 25 °C. After 
the incubation period, 8 pL of a 125 mM solution of SANA in 1-methyl-2- 
pyrrolidinone is added and absorbance at 4 10  nm is continuously followed 
for the first three minutes in a therm ostatted  cell at 25 °C . SANA in buffer 
is used as reference.
Amino Acid Analysis. Protein or peptide samples (200 p q )  were 
hydrolyzed with 6 N HCI a t  110°C  for 24 hr in vacuo. Protein samples 
exposed to cigarette smoke were pretreated by ultrafiltration before amino 
acid analysis. Millipore Ultrafree-PF filter units with a molecular weight 
cutoff of 10 ,000  were used. Amino acids were separated and quantitated 
by HPLC in an Amino Quant® column (Hewlett-Packard) using ortho- 
phthalaldehyde and 9-fluorenylmethylformate (FMOC, used for proline 
secondary amino group derivatization) precolumn derivatization according to 
Schuster and Apfel (78). Analysis of cysteine and tryptophan w as not 
performed. Formation of methionine sulfoxide w as determined using the 
method described by Shechter et al. (79) with minor modifications. Briefly, 
lyophilized samples were dissolved in 80%  formic acid and allowed to react 
with cyanogen bromide (CNBr) (100-fold excess) for 24  hour at room 
temperature. Cyanogen bromide reacts with the protein, cleaving the 
peptide bond at the carboxyl end of methionine and forming homoserine
lactone. Methionine sulfoxide (or sulfone) residues do not react with 
cyanogen bromide. The reaction w as stopped by addition of an equal 
volume of water, then frozen and lyophilized. The cyanogen bromide 
peptides were hydrolyzed as described above but in the presence of 1 % 
(w/v) 1 ,4-dithiothreitol in order to reduce methionine sulfoxide back to 
methionine. In this manner, the  value obtained for methionine w as taken as 
methionine sulfoxide, and original methionine concentrations in the  protein 
were obtained from levels of homoserine lactone. Although this analysis for 
oxidation of methionine gave reproducible and accurate  results from control 
experiments using oxidized o1PI with H20 2 and chloramine-T, one 
complication arose. Homoserine lactone coelutes with glycine in the HPLC 
separation of the  acid hydrolysates, both amino acids eluting as a single 
peak. We changed the solvent gradient in order to achieve tw o resolved 
peaks for these  amino acids but noticed tha t the changes introduced always 
resulted in losses of resolution for other amino acids. Therefore, without 
changing the conditions recommended by Shuster and Apfel (78), non­
oxidized methionine concentrations were obtained from the difference of 
glycine plus homoserine levels found in CNBr analyses minus glycine levels 
obtained from analyses without cyanogen bromide. Response factors used 
for quantitative analysis of amino acids were calculated from calibration 
curves derived from four different dilutions of 2.5 mM amino acid standard 
solutions in 0.1 N hydrochloric acid (Sigma Chemical Co).
HPLC. The products obtained from the different reactions carried out 
with MER10 were isolated by semipreparative reverse-phase HPLC in an 
Econosil® C18 10U Alltech column (10 jjm, 250x10  mm) (Alltech 
Associates, Inc., Deerfield, II) using a detection wavelength of 2 10  nm. The 
com ponents of the  reaction mixture were separated using a flow rate of 3 
mL/min and an initial eluent composition of 80%  water, 15%  acetonitrile 
and 5%  isopropanol which w as linearly increased to 95%  acetonitrile and 
5%  isopropanol over a period of 45 min. All solvents contained 0.1 % 
trifluoroacetic acid. After isolation, organic solvents were evaporated under 
vacuum, and water w as eliminated by lyophilization. Structural studies of 
these  peptide fractions were carried out by amino acid analysis, m ass 
spectrom etry and NMR.
NMR Analysis of MER10. The concentrations of the peptide samples, 
determined from peak areas obtained during the HPLC isolation, were 
estimated to  be betw een 1.2 and 0 .8  mM. All NMR spectra  were recorded 
at 25 °C in D20  and at 37 °C in DMS0-d6 on a Bruker AM-400 
spectrom eter operating at 4 0 0 .1 3  MHz equipped with an Aspect 3 000  
computer. The chemical shifts were relative to internal sodium 3- 
(trimethylsilyl)[2,2,3,3-d4] propionate (TSP) in D20  and, when dimethyl 
sulfoxide-d6 w as the  solvent, the  residual signal due to DMSO at 2 .49  ppm 
w as taken as reference.
One-dimensional spectra  were collected with 8 K complex data points
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over a 360 0  to 5000  Hz sw eep  width with a minimum of 64 and a 
maximum of 640  scans. The residual HOD and H20  signals from D20  and 
dimethyl sulfoxide-d6, respectively, were suppressed by low-power 
presaturation prior to  data acquisition.
Two-dimensional correlation spectroscopy experiments (COSY) were 
obtained in the magnitude mode with 1024-2048 complex data points in t2 
and 256-300 data points in f1f each point being the sum of 32 scan 
accumulations. Zero filling in and t2 dimensions w as performed, and both 
dimensions were always apodized with an unshifted sine-bell curve before 
transformation.
For relayed experiments the standard Bruker microprograms were 
used. For examlple, the following is the pulse sequence used for a one-step 
relayed experiment: D1 -P1-D0-P1-D2-P2-D2-P1 -ACQUISITION, where D1 is 
the relaxation time (2.0 s), DO is the incrementable delay time for two- 
dimensional acquisition (3 / j s  at t 0), D2 is a delay time (18 ms), P1 is the 
9 0 °  pulse and P2 the 180° pulse.
Time-of-Flight MS Analysis. All m ass spectra were obtained on a 252Cf 
Plasma Desorption Time-of-Flight Bio-Ion 20  mass spectrom eter (Bio-Ion, 
Uppsala, Sweden). Plasma desorption m ass spectrometry (PDMS) utilizes a 
252Cf source to ionize molecules, which subsequently are analyzed using the 
time-of-flight technique. PDMS provides optimal soft ionization preventing 
fragmentation of biological molecules of high molecular weight.
RESULTS
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Inactivation of Alpha-1-PI by Direct and Indirect Exposure to Gas- 
Phase Cigarette Smoke. It has already been reported that direct exposure of 
or1 PI to gas-phase cigarette smoke results in the inactivation of the protein, 
and that this occurs in a biphasic process (53); this is show n in Figure 1.1.
An initial rapid loss of elastase inhibitory capacity of about 20%  occurs 
during the first hour of incubation with gas-phase cigarette smoke. This fast 
inactivation is followed by a slower one. After 24  hours the total loss of EIC 
is about 60% . To explain this biphasic loss of EIC, it was proposed that the 
inactivation of a1PI by direct exposure to gas-phase smoke is brought about 
by tw o different mechanisms (53). Short-lived species formed by reactions 
of free radicals in the smoke were proposed to be responsible for the fast 
a1PI inactivation. These metastable species would be unlikely to be 
involved in the slow inactivating process observed with solutions of cigarette 
smoke tha t require several minutes to be prepared. As to the species 
responsible for the o1 PI inactivation that follows the fast phase, 
autoxidizable smoke com ponents that would cooxidize with a1PI were 
proposed. No structural analysis of the smoke-exposed inhibitor has been 
reported to sustain these  hypotheses.
The approach taken to investigate whether distinct mechanisms 
operate during the fast and slow inactivation of o1 PI w as to study the amino
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FIGURE 1.1. Inactivation of Alpha-1-PI by Direct Exposure to Gas-Phase 
Cigarette Smoke. Alpha-1-proteinase inhibitor (125 //g/mL) w as exposed to 
gas-phase cigarette smoke (one 1R1 cig/mL)in buffer and incubated at 
37  °C. Aliquots were withdrawn at the indicated times and assayed for 
anti-elastase activity as described in the Experimental section. The insert 
show s an expansion of the plot over the first 100 minutes. Each data point 
is the  average of duplicate m easurem ents of tw o independent 
determinations.
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acid composition of o1PI exposed to cigarette smoke by tw o different types 
of exposures: direct and indirect (see Experimental section). Indirect 
exposure of crl PI to gas-phase cigarette smoke does not cause a fast, initial 
inactivation, and only the continuous, slow loss of EIC is observed (53).
The lack of the fast inactivating phase after indirect exposures of crl PI to 
cigarette smoke suggests  that the "early mechanism" does not operate, and 
inactivation of the inhibitor is brought about by the "slow mechanism".
We allowed the smoke solutions used for the indirect exposures to  
age for periods of 6 and 24  hours before adding crl PI. The EIC determined 
for these  smoke-exposed crl PI solutions, using both direct and indirect 
protocols, is shown in Table 1.1. After 24  hours of incubation, o lPI exposed 
directly to gas phase smoke exhibits a decrease in EIC of about 47% . The 
crl PI exposed to previously prepared solutions of gas phase smoke aged for 
6 hours before addition of o1PI show s a decrease in EIC of about 20% , 
while the inhibitor exposed to smoke that was first aged for 24  hours 
remains fully active. These results indicate tha t the inactivating capacity of 
the smoke decreases with time, and that smoke aged for 24  hr has lost all 
capacity to  impair crl PI as an inhibitor of elastase.
Table I.II show s the amino acid composition of o1PI after having been 
exposed to cigarette smoke. The direct exposure of a1PI to gas-phase 
cigarette smoke causes  the oxidation of one of the eight methionine residues 
present in the native protein to methionine sulfoxide. Indirect exposure of
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TABLE I.I. Effect of Aging on the Inactivating Capacity of Gas-Phase 
Cigarette Smoke.
incubation Time 
of Smoke Sln“. (hr)
% Activity % Inactivity %EIC ±  S.D.b
Control® 6.3 93 .7 100 .0  ±  0 .0
0 d 50.7 49 .3 52 .6  ±  1.5
6 24.7 75 .3 8 0 .4  ±  0 .9
24 5.1 94.9 101.3  ±  0 .6
• Gas-phase smoke solutions (1 cig./mL) were allowed to age in the absence 
of crl PI for the indicated periods of time at 37 °C. After these  aging periods 
of the smoke solutions, a1PI w as added (125 //g) and solutions were 
incubated for an interval of 24  hrs at 37 °C before determination of EIC. 
b Percent elastase inhibitory capacity (%EIC) is indicated as the average of 
three experiments ±  standard deviation.
0 The control consisted of a solution of orlPI incubated for 24  hr in the 
absence  of smoke solution at 37  °C.
d Exposures to smoke not aged (0 hour) are equivalent to direct exposure.
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TABLE I.II. Amino Acid Analysis of crl PI Exposed to Direct Gas-Phase and 
to Indirect Aged Cigarette Smoke*.
A.Acid Literature1 Control 0 hr' 6  hr6 24  hr*
Asx 11.1 ±  1.1 12 .4  ±  0 .3 12 .8  ±  0 .4 12 .6  ± 0 .2 12 .4  ±  0 .3
Glx 12.9  ±  0 .9 12 .8  ±  0 .3 13 .5  ±  0 .4 13.5  ±  0 .4 13.2  ±  0 .4
Ser 5 .3  ±  0 .2 4 .5  ±  0.1 4 .6  ±  0 .0 4 .6  ±  0 .0 4 .5  ±  0 .0
His 3 .3  ±  0 .2 3 .6  ±  0.1 2 .6  ±  0.1 3.1 ±  0.1 3.1  ±  0.1
Gly 5 .6  ±  0 .2 5 .7  ± 0 .4 5 .8  ±  0 .4 5 .8  ±  0 .4 5 .8  ±  0 .4
Thr 6 .8  ±  0 .6 8 .0  ± 0 .3 8 .2  ±  0 .0 8 .2  ±  0 .0 7 .9  ±  0 .2
Ala 6.1 ±  0 .3 5 .9  ± 0 .0 6 .2  ±  0 .0 6 .2  ±  0.1 6 .2  ±  0.1
Arg 2 .0  ±  0 .2 2 .0  ±  0 .0 2 .0  ±  0.1 2.1 ±  0 .0 2 .0  ±  0.1
Tyr 1.5 ±  0.1 1.6 ±  0 .0 1.6 ±  0.1 1.6 ±  0 .0 1.6 ±  0 .0
Val 6 .3  ±  0 .7 6 .8  ±  0 .0 7 .0  ±  0 .0 6 .9  ±  0.1 6 .8  ±  0 .0
MetSO 0 0.1 ±  0 .0 0 .2  ±  0 .0 0 .4  ±  0 .0 0.1 ±  0 .0
lie 4 .8  ±  0 .5 5 .5  ± 0 .4 5 .3  ±  0 .2 5.1 ±  0 .4 5 .2  ±  0 .2
Phe 6 .8  ±  0 .6 7.1 ±  0 .0 7 .4  ±  0 .2 7 .2  ±  0.1 7 .2  ±  0.1
Leu 11.9  ±  1.2 11 .4  ± 0.1 11 .9  ±  0 .2 11 .5  ±  0 .2 11 .8  ±  0.1
Lys 8 .8  ±  1 .2 7 .0  ±  0.1 5.1 ±  0.1 5 .7  ±  0.1 6 .5  ±  0 .2
Pro 4 .8  ±  0 .9 4 .2  ±  0.1 4 .2  ± 0 .0 4 .2  ±  0 .0 4 .2  ±  0 .4
M et 2 .0  ±  0 .2 1.8  ±  0.1 1.5 ±  0.1 1.4  ±  0.1 1.7 ±  0.1
° Amino acid amounts are expressed as mol percent ±  standard deviation of 
duplicate determinations.
b Averaged values of amino acid compositions of human o1PI obtained from 
previous publications (40,80-82).
c Times indicated correspond to the intervals used to age the cigarette 
smoke solutions (see Table 1.1 legend). The compositions of residues which 
show  significant changes are highlighted.
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a1PI to gas-phase smoke aged for 6 hr results in the oxidization of tw o 
methionine residues, but smoke aged for 24  hr does not oxidize methionine. 
Table I.II also indicates that direct exposure of o1PI to cigarette smoke 
causes depletions of about 27%  of His residues relative to the control, while 
protein exposed to smoke aged for 6 or 24  hr show s depletions of this 
residue of about 14%. Changes in lysine levels are also significant in some 
of these  smoke-exposed protein samples. Direct exposure of o1PI to 
cigarette smoke causes 27 % depletion of Lys; 19% disappearance is 
detected  for o1 PI exposed to  smoke aged for 6 hours, and the inhibitor 
exposed to the smoke aged for 24  hours does not show  significant changes 
in lysine levels. Smoke aged for 24  hours modifies His residues but does 
not affect the elastase inhibitory capacity of o1PI (Table 1.1), indicating that 
the integrity of His residues is not essential for the activity of o1PI. A 
correlation betw een amino acid composition and EIC, measured for o1PI 
exposed to direct smoke and to smoke aged for 6 hours, is not obvious.
It has been extensively documented tha t alpha-1-proteinase inhibitor 
loses its e lastase inhibitory capacity upon enzymatic (45,66) or chemical 
(40 ,42 ,63 ,73 ,74) oxidation of a methionine residue, Met358, present in its 
active site. Figure 1.2 show s the correlation betw een the number of 
methionine sulfoxide residues formed in o1PI upon reaction with hydrogen 
peroxide and the EIC determined for the oxidized inhibitor. Johnson and 
Travis (40) reported a loss in EIC of 95%  with a maximum of two
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FIGURE 1.2. Correlation Between the Number of Methionine Residues 
Oxidized to Methionine Sulfoxide and Elastase Inhibitory Capacity for 
Alpha-1-PI. Alpha-1-PI (2.3 //M) was allowed to react with different 
concentrations (30 fjM  to 30  mM) of H20 2 (30% solution, w/v) in a final 
volume of 1 mL phosphate buffer at room temperature. Aliquots of 120 //L 
were withdrawn, 60  pL of which w as used for EIC determination. The 
remaining volume w as immediately frozen and then  lyophilized prior to 
quantitative analysis of methionine sulfoxide (see Experimental section). 
Each data point is the average of duplicate m easurem ents of one 
determination.
methionine residues oxidized when crlPI is allowed to  react with 
N-chlorosuccinimide. Figure 1.2 indicates that 8 methionine residues need to 
be oxidized, using H20 2 as the  oxidant, before complete inactivation of o1PI 
is achieved. This difference in the number of oxidized methionine residues 
required to accomplish complete inactivation of a1 PI could be explained by 
the different sizes and, therefore, selectivities of the oxidants used in these  
two experiments. Hydrogen peroxide is a smaller molecule which could 
probably oxidize Met residues inaccessible to N-chlorosuccinimide. It has 
not been established that oxidation of Met residues other than Met358 
renders the protein inactive. Similar differences in the  selectivities of several 
oxidants used during the oxidative inactivation of <71PI have previously been 
show n (83).
The results obtained with H20 2 (Fig. 1.2) resemble the results we 
obtain with o1PI exposed to  indirect cigarette smoke, where oxidation of 
tw o Met residues results in about 25%  loss of EIC. By this sam e rationale, 
the  loss of 47%  EIC observed in a1PI after direct exposure to  gas-phase 
smoke cannot be explained solely on the basis of methionine oxidation since 
the oxidation of one Met should have resulted in only a 20%  loss of EIC.
This observation suggests  that depletion of Lys (Table I.II) by cigarette 
smoke contributes to the inactivation of o1PI.
Alpha-1-PI Inactivation by Filtered Smoke. As s ta ted  in the 
experimental section, filtered smoke represents more faithfully the smoke to
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TABLE Mil. Inactivation of crlPI by Direct Exposure to Gas-Phase and Filtered 
Cigarette Smoke".
Addition %Activity %lnhibition % EIC
Control1* 3 .4 96 .6 100 .0
Gas-Phase Smoke 52.3 47 .7 4 9 .4  ±  6.5
Filtered Smoke 53.2 46 .8 4 8 .4  ±  9.8
“ In a final volume of 1 mL of buffer, a1PI (125 //g) w as exposed to either 
gas-phase or filtered smoke from one cigarette. Solutions were incubated 
for an interval of 24  hr at 37 °C before determination of EIC. 
b The control consisted of a solution of cr1 PI incubated for 24  hr in the 
absence  of smoke solution a t  37  °C.
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TABLE I.IV. Amino Acid Analyses of Alpha-1-Proteinase Inhibitor Exposed to 
Gas-phase and Filtered Cigarette Smoke*.
Residue Control Gas-Phase Filtered
Asx 11.9 ±  0 .2 12.1 ±  0.1 12.1 ±  0 .2
Glx 12.8 ±  0 .4 12.8 ±  0 .3 12.8 ±  0 .6
Ser 4 .7  ± 0.1 5 .0  ±  0.1 4 .9  ±  0.1
His 3 .3  ± 0.1 2 .4  ± 0.1 2 .5  ±  0.1
Gly 5.9 ± 0 .2 6.1 ±  0 .2 5 .9  ±  0.1
Thr 6 .8  ±  0.1 6 .9  ±  0 .3 6 .9  ±  0 .0
Ala 6 .7  ± 0 .2 6.9 ±  0.1 6 .8  ±  0 .0
Arg 2.5 ± 0.1 2 .6  ±  0.1 2 .5  ±  0.1
Tyr 1.5 ±  0 .0 1.5 ±  0 .0 1.6 ±  0 .0
Val 6.2 ±  0 .2 6 .4  ±  0.1 6.5 ±  0 .0
MetSO 0.1 ± 0 .0 0 .2  ± 0 .0 0 .6  ±  0 .2
lie 4 .7  ±  0 .2 5 .0  ±  0 .2 4 .9  ±  0.1
Phe 6.5 ± 0 .3 7 .0  ±  0.1 6 .6  ±  0 .0
Leu 12.1 ± 0 .2 12.0 ±  0.1 12 .4  ±  0 .2
Lys 8 .0  ±  0.1 5.8 ± 0 .3 7 .3  ± 0 .2
Pro 4 .3  ±  0 .3 4 .0  ±  0 .4 4 .4  ±  0 .7
Met 1.8 ± 0.1 1.7 ± 0.1 1.3 ± 0.1
* Amino acid amounts are expressed as mol percent ±  standard deviation of 
duplicate determinations of three experiments. The compositions of residues 
which show  significant changes are highlighted.
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FIGURE 1.3. Amino Acid Analysis of crIPI Exposed to Direct Gas-Phase 
Cigarette Smoke. Alpha-1-PI (125 /yg) w as exposed to direct gas-phase 
smoke from one cigarette and incubated for 24  hr at 37 °C in a final volume 
of 1 mL of buffer (chromatogram A). The control (chromatogram B) 
consisted of a solution of orl PI treated as above but in the absence of 
cigarette smoke. Amino acid concentrations which exhibit changes with 
respect to the control are indicated by arrows. Methionine sulfoxide 
formation is not show n (see Fig. 1.4).
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FIGURE 1.4. Amino Acid Analysis of crIPI Exposed to Direct Filtered Smoke 
After Cyanogen Bromide Treatment. Amino acid analysis of crIPI exposed to 
filtered smoke (chromatogram A) and of control olPI (chromatogram B). 
Experimental conditions are described in Fig. 1.3 legend. As indicated by the 
arrows, methionine sulfoxide appears as methionine, and unoxidized 
methionine coelutes with glycine as homoserine lactone (see Experimental 
section for description of cyanogen bromide treatment).
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which cigarette consum ers are exposed. This argum ent leads us to 
determine the extent of o1 PI inactivation brought about by this type of 
smoke. We find tha t direct exposure of or1 PI to filtered smoke produces an 
equivalent loss of EIC as that induced by gas-phase smoke; these  results are 
show n in Table I.III. Amino acid analyses of the protein samples (Table I.IV) 
exposed to filtered and gas-phase smoke suggest that, although both types 
of smoke cause  a similar loss of EIC, the causes for inactivation may differ. 
Alpha-1-PI exposed to filtered smoke contains about tw o methionine 
sulfoxide residues as compared to one methionine sulfoxide detected in the 
protein exposed to  gas phase. Lysine levels in the protein exposed to 
filtered smoke are decreased by approximately 10% relative to  Lys levels in 
the control, while o1PI exposed to gas-phase show s Lys depletion of about 
28% . Both smoke-exposed proteins contain decreased amounts of His 
(24% decrease) as compared to the control. The HPLC chromatograms 
obtained from the amino acid separation of the acid-hydrolysates of the 
smoke-exposed crIPI samples and of the control are show n in Figures 1.3 and 
1.4. Figure 1.3 clearly show s a decrease in the levels of His and Lys in the 
protein exposed to  gas-phase smoke, while all other amino acids are not 
significantly changed. Samples used for the acquisition of the 
chromatograms show n in this figure had not been treated with cyanogen 
bromide prior to acid hydrolysis; therefore, methionine oxidation is not 
detected. Figure 1.4 show s the extent of methionine oxidation in a1PI
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exposed to filtered smoke and illustrates the usefulness of cyanogen 
bromide treatm ent in samples containing oxidized methionine residues.
Reaction of Free Amino Acids with Gas-Phase Cigarette Smoke. The 
reaction of cigarette smoke with free amino acids w as studied in an effort to 
identify products which could explain the observed depletions of Lys and His 
residues in a1Pi after exposure to smoke (Tables I.II and I.IV). Identification 
of these  modified residues would give important information regarding the 
nature of the species, present in cigarette smoke, responsible for the 
inactivation of a1 PI. Using free amino acids in place of the protein allows us 
to  bypass the harsh conditions required for protein hydrolysis (see 
Experimental) and might reveal the presence of products destroyed during 
the acid-hydrolysis step. For example, some of the products, such as imines 
formed from carbonyl compounds found in smoke (1,18,19) and primary 
amines in the protein, could be labile to acid hydrolysis. Derivatization of 
the amino acids after the reaction is still necessary due to the low extinction 
coefficient of the amide group a t 210 nm, and also to distinguish amino 
acids from smoke com ponents th a t  also absorb at this wavelength.
Although we were unable to detect products of His or Lys resulting 
from exposure to cigarette smoke, the results show n in Table I.V reconfirm 
our previous observation that these  amino acids are depleted by smoke.
These results also suggest that the  reactivity of the three amino acids tested 
follows the order: His >  Lys >  Met. Figure 1.5 show s the
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TABLE I.V. Direct Exposure of Free Amino Acids to Gas-Phase Cigarette 
Smoke”.
Amino Acid % Disappearance1*
Lys 58 ±  6
His 71 ±  1
Met 33 ±  6
”A solution (final volume of 1 mL) containing Lys, His, Met, and Val (all 85 
j j M )  w as exposed to  gas-phase smoke delivered from one 1R1 cigarette, and 
incubated a t  37  °C for a period of 48  hrs. After the incubation period, 
direct amino acid analysis was performed as described in the Experimental 
section.
b Amino acid concentrations were calculated using Val as internal standard, 
and percent disappearance values are expressed as the average ±  s.d . of 
tw o experiments.
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FIGURE 1.5. Direct Exposure of Free Amino Acids to Gas-Phase Cigarette 
Sm oke. A solution (final volume of 1 mL) containing approximately 1 mM 
concentrations of Lys, His, Met and Val w as exposed to gas>phase sm oke  
delivered from one 1R1 cigarette and incubated at 3 7  °C for a period of 48  
hrs. After the incubation period, amino acid derivatization with ortho- 
phthalaldehyde w as performed as described in the Experimental section . The 
initial reaction mixture (chromatogram A) and the amino acid mixture 
exposed to cigarette smoke (chromatogram B) are show n.
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HPLC traces obtained for the separation of the ort/jo-phthalaldehyde 
derivatives of the starting mixture and of the amino acids exposed to 
cigarette smoke. While the concentration of Val remains virtually unchanged 
after smoke exposure, His, Lys, and Met concentrations sharply decrease. 
This figure also illustrates the oxidation of Met to MetSO by cigarette 
smoke.
Assignment of the NMR 1H Spin System s Observed for the Amino 
Acid Residues in the Decapeptide MER10. The detection of products formed 
in the reaction of amino acids with cigarette smoke encounters tw o major 
difficulties. Firstly, most amino acids do not contain a distinct natural 
chromophore which would facilitate the detection of products formed in low 
yields; therefore, they require derivatization of the a-amino group before 
analysis. Since it appears that amine functionalities in a1PI undergo reaction 
with com ponents present in the smoke, detection of these  products does 
not occur, and amino acids must be labeled prior to reaction with cigarette 
smoke. The use of amino acid derivatives with chromophores that strongly 
absorb in the visible region, such as N-a-p-nitrophenyl derivatives, presents 
new  complications since the chromophore itself appears to react with smoke 
components. The second complication encountered with the use of free 
amino acids (or derivatives of these) is the separation of the reaction 
products from cigarette smoke components. Cigarette smoke is an 
extremely complicated mixture with a large number of com pounds absorbing
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in the 200  to 4 4 0  nm range thereby masking the detection of products 
formed in the reaction with amino acids.
To circumvent these  impediments, we studied the reaction of 
cigarette smoke with a synthetic peptide (MER10) containing part of the 
primary sequence found in the  active site of alpha-1-PI (40). The use of this 
decapeptide has several advantages; MER10 is a better model for a1PI than 
are free amino acids; due to its relatively large size its purification after 
reaction with smoke is no longer an obstacle, and direct analysis of the 
products by NMR and MS becom es possible.
Before the NMR spectra  of products obtained from reactions involving 
MER10 could be interpreted, an assignment of all ^  NMR resonances of 
hydrogen a tom s in MER10 had to  be performed.
When deuterium oxide (D20) is used as the solvent, all labile protons2 
in MER10 are exchanged for deuterium atoms, and only the carbon-bound 
hydrogens are observable in the  1H NMR spectrum. The nonlabile protons of 
each amino acid residue in MER10 form a unique spin system  which allows 
unambiguous identification. A spin system  is defined as the group of spins 
connected through-bond spin-spin couplings within a residue (84). All 
nonlabile protons in MER10 (H-Pro-Met-Ser-lle-Pro-Pro--Val-Lys-Phe-OH)form
2 Labile protons in MER10 are all the backbone amide protons, 
€-NH2 in Lys, and -OH in Ser. These protons undergo rapid exchange 
with deuterium atom s of the solvent and are not NMR-observable in 
D20  solution.
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a single spin system  with the exception of Met and Phe. The eCH3 group of 
Met is not connected with the  oCH-/?CH2-kCH2 fragment, and the  aromatic 
protons of Phe are not connected with the aCH2-/?CH2 fragment. The 
strategy used for the  assignm ent of the NMR signals observed in MER10 is 
described below.
1. Identification of the  spin system s formed by the nonlabile protons 
for all ten residues in D20  solution w as accomplished using COSY, 
RELAYED-COSY, and DOUBLE-RELAYED-COSY to assign 1H-1H 
connectivities.
2. identification of the connectivities for the labile protons in DMSO-de 
solutions w as accomplished using RELAYED-COSY. NH hydrogens in MER10 
do not exchange with the solvent and are therefore observable by NMR, 
allowing complete assignment of all residue spin system s.
The COSY spectrum of MER10 in D20  solution is show n in Figure 1.6. 
To facilitate the  reading of this COSY, the more familiar 1D spectrum  with 
the assignm ent of all resonance lines of MER10 is also show n along the w2 
axes of the 2D spectrum. Inspection of the COSY connectivities in this 
spectrum  reveals the presence of three easily distinguishable spin system s; 
these  are Val, lie and Lys. The connectivities for Val are show n below the 
diagonal and have a pattern containing tw o intense kCH3-/?H cross peaks and 
an intense /?H-oH cross peak, lie has the most complex spin system  but is
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FIGURE 1.6. COSY Spectrum  of MER10 in D20  Solution. All resonance  lines 
are assigned in the 1D NMR spectrum  show n in the  upper part of th e  figure. 
The connectivities of Phe (dashed lines) and of Glu (solid lines) are show n 
above the  diagonal. The spin system  conectivities of Val are show n below 
the  diagonal. The arrow  above the diagonal indicates the  trans Pro 
conformer.
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easily distinguishable from others, it is composed of tw o 6CH3-yCH2 cross 
peaks and one kCH3-£H cross peak appearing at high field, tw o yC 
cross peaks and one /?H-oH cross peak. The connectivites of the Lys spin 
system  are show n in a latter figure. The connectivities of tw o other spin 
system s are show n above the diagonal; these  are Glu (dashed lines) and Phe 
(solid lines). Another prominent feature of this COSY spectrum  is the fact 
tha t only Phe and all three Pro show  both oH-/?H cross peaks. Methionine, 
Glu, and Ser spin system s exhibit degeneracy of the 0H  protons and only 
one of the two oH-yffH cross peaks is observed. For example, the tw o oH-/?H 
cross peaks of Ser are overlapped since both fiH protons have nearly 
identical chemical shifts and the yffH-yff’H cross peak is covered by the 
diagonal.
Figure 1.7 show s the  DOUBLE-RELAYED-COSY spectrum  of the 
peptide in D20 .  The connectivities of Lys (solid lines) and the amino terminal 
Pro (dashed lines) are indicated below the diagonal. Above the diagonal, the 
connectivities for Met are shown. Apart from these three spin system s, 
RELAYED cross peaks, absen t in the COSY spectrum (Fig. 1.6), are labeled in 
this figure.
Although this NMR analysis of MER10 is not aimed a t studying the 
conformation of the  peptide, it is worth noting the different spin system s 
exhibited by the  three Pro residues. Proline residues numbered with Roman 
numerals superscripts II and III (arbitrarily assigned) are located in the middle
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FIGURE 1.7. DOUBLE-RELAYED-COSY Spectrum of MER10 in D20  Solution.
The com plete spin system s for lysine (solid lines) and amino terminal proline 
(P‘, dashed  lines) are show n below the diagonal. All connectivities for the 
spin sys tem  of methionine are show n above the diagonal. RELAYED-COSY 
cross  peaks not observed in COSY spectrum  (Fig. 1.6) are labeled using the 
one-letter nomenclature system  for amino acids.
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of the  peptide in be tw een lie and Glu residues. Their spin sy s tem s are 
analogous in tha t  the  SCH2 protons are nonequivalent, each  residue having a 
6’H-SH cross peak. In the  amino terminal Pro residue (P*), the  «TCH2 protons 
are equivalent and the  spin system  does not contain a S'H-SH c ross  peak. 
Proline residues in proteins usually adopt a trans conformation a t  the  peptide 
bond (85), but c/s peptide bonds have been reported to  occur in proline 
oligomers (86). Scheme 1.1 show s tha t the  a and 6 protons of the  proline 
ring change positions with respect to the  carbonyl group. By correlating 
NMR spectral data with optical rotation changes in proline oligomers, it has 
been show n th a t  in polar solvents the 6  protons of the  cis conformer appear 
a t  higher field than  the corresponding protons of the trans conformer (86).
SCHEME 1.1,
chain
c h a in
ds trans
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Inspection of the structures of these  tw o conformers (Scheme 1.1) suggests  
tha t  the trans peptide bond should be more favorable since it allows 
maximum separation between the tw o chains. Similarly, in MER10 the two 
internal Pro residues (Pro" and Pro"1) should favor the  trans conformation, 
thus diminishing interaction betw een the peptide chains. This argument is in 
agreem ent with the observation tha t the resonance signals due to the <SH 
protons in Pro" and Pro'" appear at lower field than the resonance lines due 
to the  £H protons in Pro1. In the terminal Pro1 residue, there is little energy 
difference between the tw o forms and although the cis conformer is usually 
observable, the trans form is also observed (this show n with an arrow in 
Fig 1.6, above the  diagonal).
The assignment of the spin system s of all amino acid residues in 
MER10 is completed by identification of the connectivities of the labile 
protons in DMSO solution. Figure 1.8 show s two expanded regions of the 
TRIPLE-RELAYED-COSY spectrum  of the peptide in DMSO solution. All 
arH-/?H cross peaks, in addition to  other signals already discussed above, are 
show n in the expansion on the upper part of the figure (2.60 to 4 .6 5  ppm 
along a;1). The expanded region on the bottom of Fig. 1.8 show s the 
connectivities between the NH-oH cross peaks and the NH-/7H cross peaks 
of all residues except for the tw o internal Pro residues (Pro1 and Pro111) which 
do not contain NH protons. The terminal Pro residue show s tw o NH-aH 
cross peaks, indicating that the imino group is probably undergoing
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FIGURE 1.8. Expanded Regions of TRIPLE-RELAYED-COSY Spectrum  of 
MER10 in DMSO(</0) Solution. All spin sy s tem s ' connectivities are show n. 
NH-oH cross peaks are labeled using the one-letter nomenclature system .
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FIGURE 1.9. Expanded Regions of DOUBLE-RELAYED-COSY of MER10 and 
Methionine Sulfoxide-Containing MER10 in D20  Solution. The expanded 
regions shown contain the aH-/?H cross peaks for both MER10 (spectrum A) 
and MER10(SO) (spectrum B).
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pyramidal inversion at the nitrogen. The e-NH protons of Lys are also 
observable in the  RELAYED-COSY in DMSO-de solution, allowing the 
establishment of the complete spin system  for this residue.
Since the oxidation of Met residues to MetSO in a1PI has already 
been show n to result in the inactivation of the inhibitor, we identified the 
spin system  of MetSO in the hydrogen peroxide-oxidized peptide. Figure 1.9 
show s the regions containing the  orH-ySH cross peaks for both MER10 and 
MER10(SO). Examination of this figure reveals the only observable change 
in this portion of the spectrum upon oxidation of Met to MetSO is a shift to 
low field of the aH-/?H and orH-yH cross peaks of MetSO when compared to 
the equivalent cross peaks of Met in MER10. In DMS0-d6 solution 
(Fig. 1.10), the Ser NH-oH cross peak in the oxidized peptide shifts towards 
low field relative to the analogous cross peak in MER10, while all other NH- 
orH cross peaks remained practically unchanged.
NMR Studies of the Reaction of MER10 with Cigarette Smoke. 
Substantial evidence is provided above indicating that cigarette smoke is 
capable of oxidizing Met residues in o1PI to the corresponding sulfoxide. 
Possible species in smoke responsible for the oxidation of Met resulting in 
the  inactivation of alpha-1-PI are benzenediols. Cigarette smoke contains 
high concentrations of polyhydroxybenzenes (1 ,18 ,19 ,75), the most
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FIGURE 1.10. Expanded Regions of TRIPLE-RELAYED-COSY Spectrum of 
Methionine Sulfoxide-Containing MER10 in DMSO Solution. Connectivities 
are only show n for Met and Ser spin system s.
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abundant being catechol and hydroquinone3, which during autoxidation 
produce hydrogen peroxide (87,88). Cigarette smoke is known to produce 
hydrogen peroxide (20,21) at concentrations reaching 130 //g per cigarette 
after 4  hours (22).
In view of the possible role of benzenediols in the oxidation of Met, 
we studied the reaction of MER10 with a mixture of cathechol and 
hydroquinone (see Experimental). Figure 1.11B show s the 1D NMR spectrum 
of the  major product isolated from this reaction (aromatic protons are not 
shown). The most prominent feature of this spectrum  is the presence of a 
sharp singlet at 2 .6  ppm not observed in the spectrum  of MER10 (Fig.
1.11 A). The <?-CH3 protons of Met give a singlet a t  2 .0  ppm (Fig. 1.11 A); 
upon oxidation of the sulfur atom these protons become deshielded and 
absorb at lower field (2.6 ppm). Figure 1.11C show s the 1D NMR spectrum 
of a fraction isolated from the reaction of MER10 with filtered cigarette 
smoke. This spectrum also contains a sharp singlet at 2 .6  ppm, indicating 
oxidation of methionine to the sulfoxide. Oxidation of methionine in both 
peptides, smoke-exposed and reacted with benzenediols, w as also confirmed 
by m ass spectrometry analysis. Figure 1 .12A show s the PDMS spectrum  of 
MER10 which indicates a molecular ion peak at 1144  units. The spectra of 
the  products isolated from the reactions of MER10 with benzenediols and
3Refer to Table III.III of this Dissertation for a quantitative 
determination of catechol and hydroquinone in smoke.
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FIGURE 1.11. 1H 1D NMR Spectra of MER10 Products Isolated from the 
Reactions with Benzenediols and with Filtered Smoke. Spectra w ere  
collected in D20  at 25 °C and chemical shifts are relative to  TSP. A: 
MER10; B: major product isolated from the  reaction betw een MER10 and a 
mixture of hydroquinone and catechol; C: product isolated from the  reaction 
of MER10 with filtered cigarette smoke.
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FIGURE 1.12. M ass Spectra  of Products Isolated from the Reactions of 
MER10 with Filtered Cigarette Smoke and Benzenediols. All m ass spectra  
w ere  obtained on a 2S2Cf Plasma Desorption Time-of-Flight Bio-Ion 20  m ass 
spectrom eter. A: PDMS spectrum  of MER10; B: PDMS spectrum  of a 
product isolated from the  reaction of MER10 with hydroquinone and 
catechol ; C: PDMS spectrum  of a product isolated from the  reaction of 
MER10 with filtered smoke.
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with filtered smoke (Fig. 1.12B and 1.12C) indicate the  addition of 16 m ass 
units to the molecular weight of MER10. Three peaks, with m/Z values of 
1160, 1183 and 1205 are observed in these  PDMS spectra, which 
correspond to the ions (M0 + H)+, (MO + Na)+, and (MO + 2 N a)+, 
respectively4. These results show  that tw o of the major 
polyhydroxybenzenes present in cigarette smoke, catechol and 
hydroquinone, are capable of oxidizing Met residues. Also, we have shown 
by four different analyses that cigarette smoke oxidizes methionine to 
methionine sulfoxide.
So far we have only show n disappearances of the basic amino acids 
His and Lys, and have yet to identify any product formed when <71PI is 
exposed to cigarette smoke. Since, as show n above, there appears to  be no 
correlation betw een His depletion and the EIC of a1PI, we studied the 
reaction of MER10, which does not contain His, with smoke, thereby 
focusing on modifications of Lys residues. This by no means implies that 
modifications to  His are not relevant when dealing with proteins other than 
PI.
The data in Tables I.II and I.IV suggest that depletions of Lys occur 
early in the incubation period, and that gas-phase smoke depletes Lys to a 
greater extent than does filtered smoke. In view of these  results, we
4 The notation (MO) denotes the molecular weight of MER10 (M) 
plus 16 amu.
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FIGURE 1.13. DOUBLE-RELAYED-COSY Spectrum of MER10 Exposed to 
Gas-Phase Cigarette Smoke in D20 .  This figure show s the  presence of tw o 
peptides (see text); the  connectivities show n correspond only to  amino acids 
of the  modified peptide. The spin system s of Lys (K',solid lines) and Pro (P \  
dashed  lines) are show n below the diagonal. The spin system  of Glu (G') is 
show n above the  diagonal.
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exposed MER10 to  direct gas-phase cigarette smoke by passing the smoke 
of one 1R1 cigarette every hour for a total interval of four hours, giving a 
total of four cigarettes smoked. After incubation for 12 hours at 37  °C, we 
separated by HPLC a fraction that eluted with a different retention time than 
tha t of MER10. The DOUBLE-RELAYED-COSY spectrum in D20  of this 
fraction is shown in Fig.1.13. Inspection of this figure reveals the presence 
of tw o peptides. One peptide is clearly MER10 with the familiar net of 
amino acid spin system s discussed in the  previous section. The presence of 
a second peptide is evidenced by the appearance of new  spin system s 
attributed to Lys, Glu, and one of the Pro residues; the connectivities of 
these  residues are show n in Fig. 1.13. More evidence for the presence of a 
smoke-modified peptide is the appearance of lower-field cross peaks next to 
the signals attributed to the side-chain protons for lie, Val and Phe residues 
in MER10. The spin system  which we have attributed to Lys in the modified 
peptide contains a <JCH2-eCH2 cross peak appearing at lower field (o/1 =
3.05 , a/2 = 1.72) than the analogous <JCH2-eCH2 cross peak of the MER10 
spectrum  (a/1 = 2 .9 ,  a/2 = 1.60). This <5CH2-eCH2 cross peak is connected to 
a cross peak (a/1 = 3 .5 2 ,  a/2 = 3.00) which is not observed for MER10, 
suggesting the addition of a -CH2-R group to the e-amino group of lysine.
The chemical shift of the protons in this methylene group (a/2 = 3.00, 
a/1 = 3 .4 5  ppm) suggests  that the R group is an electron withdrawing 
moiety. The cross peaks arising from the oCH-/?CH2-yCH2 fragment of this
modified Lys residue are superimposed with the Lys signals of MER10. This 
is to be expected since the  protons of the  oCH-/?CH2-kCH2 fragment are 
separated from the protons of the modified NH-CH2-R fragment by at least 
five covalent bonds. A feasible explanation for these  changes observed in 
the  spin system  of Lys would be the addition of a cyanomethyl group 
(-CH2CN) to the e-NH2 moiety. The formation of cyanomethyl derivatives of 
amines upon reaction with cigarette smoke has been in fact proposed by Yu 
et al. (71).
As a result of this modification in the lysine side chain, the spin 
system  of Glu in the modified peptide is shifted to low field with respect to 
the  Glu spin system  in MER10; the connectivities of the former residue are 
show n in Fig. 1.13. This effect on the chemical shift of the spin system  of 
glutamic acid suggests  that the side chains of Glu and Lys are in close 
proximity, in spite of the fact tha t the tw o amino acids are separated by Val. 
Lastly, a new Pro spin system  is observed (designated as P' in Fig. 1.13) 
with a strong &H-6H  cross peak and a degeneracy of the tw o /?H protons. 
This degeneracy of the  protons of P' gives rise to a single cross
peak which appears a t  lower field (a/1 = 4 .90 , w2 = 2.33) than the  oH-/?H 
cross peaks of all other spin system s. The data presented here does not 
allow us to determine unequivocally which of the three Pro residues present 
in MER10 has been modified by cigarette smoke. However, the chemical 
shift of the aH-/?H cross peak suggests  that the nitrogen atom of this residue
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FIGURE 1.14. DOUBLE-RELAYED-COSY Spectrum  of the Product Isolated 
from the  Reaction of MER10 and Formaldehyde in D20 .  The spin sys tem  
connectivities for the  amino terminal Pro residue are show n; all other amino 
acid cross  peaks are labeled using the one-letter nomenclature code.
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has undergone reaction with smoke, and the group attached to the  nitrogen 
deshields the oH proton. Only the terminal proline residue in MER10 could 
undergo such reaction since the  imino nitrogens of Pro" and Pro'" are part of 
the  amide backbone.
The DOUBLE-RELAYED-COSY spectrum  of the major product isolated 
from the reaction between MER10 and formaldehyde, a major com ponent of 
gas-phase cigarette smoke (1,18,19), is show n in Fig 1.14. A comparison of 
this figure with Figure 1.13 reveals certain similarities betw een both spectra. 
Figure 1.14 show s a spin system  assigned to the terminal Pro residue (P*), 
which resembles the Pro spin system  of the smoke-modified peptide in 
Fig. 1.13. Formaldehyde could react with proline to yield an intermediate 
carbinolamine which undergoes elimination to form an iminium ion. Evidence 
for this speculation is the presence of a strong cross peak (o» 1 = 5 .1 ,  
a;2 = 4.90) not coupled with other signals. This cross peak could be 
attributed to the vinylic protons of the iminium ion formed from the reaction 
of Pro' with formaldehyde. Another similar feature in both spectra  is the 
presence of the cross peak attributed to the <JCH2-eCH2 protons of Lys in the 
smoke-modified peptide. However, Fig. 1 .14 does not exhibit a low-field 
cross peak connected to  the <JCH2-eCH2 cross peak, suggesting the 
formation of an imine betw een the  eNH2 group of Lys and formaldehyde.
DISCUSSION
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The data presented here suggest tha t cigarette smoke inactivates 
alpha-1-proteinase inhibitor by tw o different mechanisms: oxidation of 
methionine and nonoxidative covalent modification of lysine.
Our results show  for the  first time that com ponents in cigarette smoke 
oxidize methionine residues to methionine sulfoxide in a1PI. Only one 
previous report (43) in the literature has documented the oxidation of 
methionine in a1PI as a consequence of cigarette smoking. Carp et al. (43) 
determined the presence of methionine sulfoxide in o1 PI recovered from 
bronchoalveolar lavage fluid (BAL) of cigarette smokers. In spite of the 
significance of these  findings, they did not rigorously prove that the 
oxidation of methionine resulted from the direct interaction of cigarette 
smoke com ponents with a1PI. Methionine sulfoxide, found in the inhibitor 
isolated from BAL of smokers, could result from the interaction of a 1 PI with 
phagocytic cells, present in increased concentrations in the lungs of smokers 
(65). For example, Matheson et al. (45,66) has show n that neutrophil 
myeloperoxidase inactivates o1PI by oxidizing the methionine residue present 
in the  active site.
As show n in Figure 1.1, direct exposure of orl PI to gas-phase cigarette 
smoke results in an initial fast inactivation followed by a slow inactivation 
occurring over 24 hours. Amino acid analysis of o1PI exposed to cigarette
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smoke, using protocols which would mimic these  tw o inactivation 
processes, show s that oxidation of Met occurs during both the short-term 
and long-term inactivations. These results indicate tha t these  tw o 
mechanisms of inactivation cannot be distinguished solely by amino acid 
analysis of the  exposed protein.
Nevertheless, several lines of evidence suggest that hydrogen 
peroxide, known to be produced by cigarette smoke solutions (20-22), is the 
species responsible for the  inactivation of crIPI in the slow phase. Cigarette 
smoke contains high concentrations of polyhydroxybenzenes (1 ,18,19,75), 
the most abundant being catechol and hydroquinone, which produce 
hydrogen peroxide during autoxidation (87,88). We observe that a mixture 
of hydroquinone and catechol oxidizes the methionine residue of the 
synthetic peptide MER10. Also, the pattern of inactivation of a1PI by 
hydrogen peroxide (Fig. 1.2) resembles the results obtained from indirect 
exposure of the protein to cigarette smoke. These findings confirm previous 
speculations (53) tha t the long-term inactivation of orlPI by cigarette smoke 
is a result of the cooxidation of the inhibitor with autoxidizable species 
present in cigarette smoke.
On the other hand, the data  presented here does not allow us to 
identify the species responsible for the oxidation of Met in the short-term 
inactivation. The gas-phase of cigarette smoke is known to contain 
inorganic radicals such as  nitric oxide (NO), nitrogen dioxide (NQ2), as well
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as small carbon- and oxygen-centered organic radicals (8,12). Pryor et al. 
(53) proposed short-lived species such as peroxonitrates, formed in smoke 
by the  reaction of nitrogen dioxide and organic peroxyl radicals, as the 
oxidants responsible for the fast inactivation of o1PI. Although this theory 
remains largely unchallenged, the results presented in Chapter II suggest that 
peroxonitrite, formed by the reaction of superoxide and nitric oxide, could 
play a role in the short-term inactivation of o1PI. In chapter II we show  that 
peroxonitrite is a short-lived, strong oxidant capable of inactivating o1PI by 
oxidizing methionine.
Concurrent with oxidation of Met, we observe depletions of His and 
Lys residues in o1PI exposed to  cigarette smoke. Since it had already been 
reported that modification of His has no effect on the inhibitory activity of 
olPI (67), in agreement with our observations, we did not investigate the 
mechanism by which components of cigarette smoke react with this residue. 
Although modification of His residues in a1PI appears not to be essential for 
the activity of the inhibitor, modification of His residues of other proteins by 
cigarette smoke may have significant consequences. For example, it has 
been reported that oxidative modification of one His residue in glutamine 
synthetase  causes its inactivation and subsequent proteolytic degradation 
(89-91).
With Lys, however, we observe a correlation betw een the extent of 
depletion of this amino acid and the inhibitory capacity of o1PI. Pryor et al.
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(56) found th a t  amines protect o1PI against loss of elastase inhibitory 
capacity by cigarette smoke, and Fretz and Gan (67) reported loss of activity 
of crl PI brought about by chemical modification of Lys residues. Our data, 
show n in Tables Ml and I.IV, indicate that depletions of Lys occur early in 
the reaction of a1PI with cigarette smoke, and that direct gas-phase smoke 
depletes Lys to  a greater extent than does filtered smoke. We also observe 
tha t depletion of Lys in a1PI is significantly reduced when aged smoke is 
used (Table I.II). NMR analysis of a product, isolated from the reaction of 
gas-phase smoke with MER10, suggests  the e-amino group of Lys and the 
secondary amino group of Pro react with com ponents of smoke. We have 
tentatively identified these  modified amino acids as being the  products of the 
reaction of the amino group with formaldehyde, in the case  of Pro, and with 
formaldehyde and cyanide in the  case  of Lys. These results agree with 
reports by Yu et al. documenting the formation of cyanomethyl derivatives 
of biogenic amines (71) and of basic amino acids in proteins (72) by reaction 
with formaldehyde and cyanide. However, these  authors argued tha t no 
products were formed when formaldehyde, in the absence of cyanide, was 
allowed to react with amines. Our results indicate that this reaction takes 
place, as  show n in Fig. 1.14, contradicting this observation by Yu et al. It 
has also been show n that reaction of the e-amino group of Lys with acrolein 
and other carbonyl com pounds found in cigarette smoke results in the 
inactivation of alpha-1-proteinase inhibitor (68,69).
CONCLUSION
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We have show n tha t cigarette smoke reacts with o1PI to cause 
modifications in its amino acid composition by tw o different mechanisms: 
oxidation of methionine to methionine sulfoxide and nonoxidative covalent 
modification of amines. These amino acid modifications result in impairment 
of the elastase inhibitory activity of alpha-1-proteinase inhibitor, the major 
plasma inhibitor of serine proteases (62). We have indirectly show n that 
hydrogen peroxide, formed during the autoxidation of hydroquinones found 
in smoke (1 ,18 ,19 ,75), is responsible for the oxidation of methionine, and 
that modification of amines results from their reaction with formaldehyde 
and cyanide. It is possible tha t the identification of these  com pounds in 
cigarette smoke, as the species responsible for the inactivation of o1PI, 
could aid in the development of adequate preventive medicine against 
emphysema.
CHAPTER II. Peroxynitrite Inactivates Alpha-1-Proteinase Inhibitor by 
Oxidizing Methionine.
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ABSTRACT
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The reaction of peroxonitrite5 with alpha-1-proteinase inhibitor (a1PI) 
and with a synthetic decapeptide (MER10) containing the sequence of amino 
acids found in the active site of c l  PI (Pro-Met-Ser-lle-Pro-Pro-Glu-Val-Lys- 
Phe) has been studied. Peroxonitrite inactivates o1PI under both 
physiological and basic pH conditions. Thiourea and methionine protect crlPI 
against inactivation by peroxonitrite, while mannitol, benzoate and urea 
failed to afford effective protection. The major product isolated from the 
reaction betw een peroxonitrite and MER10 was analyzed by NMR, mass 
spectrometry, and amino acid analysis. These analyses indicate that 
peroxonitrite primarily oxidizes the methionine residue in the peptide. We do 
not de tect smaller molecular weight peptides that would indicate cleavage of 
MER10 by peroxonitrite, nor hydroxylation or nitration of the phenylalanine 
residue. These observations imply that the hydroxyl radical is not the 
species responsible for the inactivation of c l  PI in this system . Our results 
suggest tha t peroxonitrite is a powerful oxidant capable of oxidizing 
methionine residues in proteins without the requisite of forming hydroxyl 
radicals and nitrogen dioxide through the decomposition of peroxonitrous 
acid. The implications of these  observations on lung diseases attributed to
5 The nomenclature often used for ONOO" is peroxynitrite. Here 
the recommended name of peroxonitrite (94) will be used.
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cigarette smoke are discussed.
INTRODUCTION
The suppression of antiprotease activity in the lung by cigarette 
smoke is one of the most widely accepted explanations for the pathogenesis 
of pulmonary emphysema in smokers (31), but the mechanism(s) by which 
cigarette smoke causes this suppression is (are) still not well understood. 
Among the major components present in cigarette smoke, nitric oxide (NO) 
has attracted very little attention.
Nitric oxide (NO) is one of the major com ponents in the gas phase of 
cigarette smoke with concentrations of up to 1000 parts per million (ppm) 
depending on the type of tobacco from which cigarettes are made (19).
Nitric oxide is slowly oxidized to nitrogen dioxide (N02) in cigarette smoke, 
and this can only be detected upon aging of the smoke (92) since fresh 
smoke does not contain N 02 (93). The reason for this is that a t 600  °C (the 
tem perature of the cigarette burning tip) the decomposition of N 0 2 is 
complete (94). The half-life of 1000 ppm NO in air is about three minutes 
(95), and it has been suggested that the oxidation of NO in the respiratory 
airways does not proceed faster (96). In spite of the fact that during 
smoking the smoke is held in the  mouth and the lungs for short periods of 
time, very little N 02 probably is formed. These facts have caused
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investigators to conclude tha t NO plays a minor role in the pathogenesis of 
emphysem a and only through its oxidation to N 0 2 (96).
Pulmonary alveolar m acrophages (PAM) have been implicated in the 
pathogenesis of emphysema, the main evidence being tha t clusters of these  
inflammatory cells collect in the  bronchioles of smokers before and during 
tissue destruction and fibrosis (97,98). The presence of cigarette smoke in 
the lung causes increased concentrations of neutrophils, another type of 
inflammatory cells, suggesting that em physem atous lesions may also result 
from the destruction of lung tissue by these cells (65). Furthermore, 
superoxide (0 2‘) production by PAM is significantly increased in the lungs of 
chronic smokers (99,100). Thus nitric oxide from cigarette smoke could 
react with cellularly-produced superoxide ion to produce peroxonitrite 
(ONOO) which has been show n to be a powerful oxidant capable of 
oxidizing thiols (101) and deoxyribose (102). The reaction of 0 2' and NO is 
diffusion-controlled in the gas phase (103) and a rate constan t of about 3.7 
x 107 M 'V 1 has been measured under physiological conditions (104). 
Alternatively, the formation of peroxonitrite in the lungs of smokers could 
arise from the reaction of NO produced by macrophages and neutrophils 
(105-107), and 0 2'  derived from PAM, which as stated above have an 
increased production of 0 2'  in smokers.
To investigate if peroxonitrite could play a role in the pathogenesis of 
emphysem a, we studied the reaction of peroxonitrite with alpha-1-proteinase
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inhibitor (o1PI). This protein is the most abundant extracellular antiprotease 
in the lung and provides most of the protection against neutrophil e lastase in 
the lower respiratory tract (36,108). We also report on the reaction of a 
synthetic decapeptide (MER10), a model for the active site of o1PI, with 
peroxonitrite. The use of this smaller molecule in place of o1PI in the 
reaction with peroxonitrite enabled us to conduct product analysis by NMR, 
m ass spectrometry and amino acid analysis.
EXPERIMENTAL
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Chemicals. Human crlPI, and porcine pancreatic elastase (El 
3 .4 .21 .36 ) were purchased from Calbiochem Co. (San Diego, CA). Bovine 
liver catalase (EC 1.11 .1 .6), bovine serum albumin, mannitol, thiourea, urea, 
methionine, sodium benzoate and N-succinyl-(L-ALA)3-p-nitroanilide (SANA) 
were all purchased from Sigma Chemical Co. (St. Louis, MO). Chelex-100® 
resin w as purchased from Bio-Rad Laboratories (Richmond,CA). MER10 (H- 
Pro-Met-Ser-lle-Pro-Pro-Glu-Val-Lys-Phe-OH) was synthesized in a 
Miliigen/Biosearh SAM 2 automatic protein synthesizer apparatus 
(Milligen/Biosearch, San Rafael, CA) as described in the Experimental section 
in Chapter I. All other chemicals were of reagent grade, and used without 
further purification. Unless otherwise indicated sodium phosphate pretreated 
with Chelex-100® was used as buffer.
Synthesis of Peroxonitrite. Peroxonitrite w as synthesized using a 
quenched flow reactor (Fig.11.1) as described by Reed et al. (109). The 
purpose of the flow reactor is to quench the acid catalyzed reaction between 
NaN02 and H20 2 with an excess  of NaOH. Base quenching of the acid 
catalyzed reaction gives the more stable peroxonitrite ion by deprotonation 
of peroxynitrous acid. Solutions consisting of 0 .6  M NaN02, 0 .7  M H20 2 in 
0 .6  M HCI, and 1.5 M NaOH were pressurized with nitrogen and passed 
through the reactor at equal flow rates (25 ± 5 mL/min). The product was
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ice bath
FIGURE 11.1. Quenched Flow Reactor Used for the Synthesis of Peroxonitrite. 
Flask A contained 0 .6  M N aN 02, flask B 0 .7  M H20 2 in 0 .6  M HCI, and flask 
C 1.5 M NaOH. All three containers were pressurized with nitrogen and the  
solutions passed  through the reactor at flow rates of 25  ±  5 mL/min. The 
product w as  collected in a flask kept at 0  °C in an ice w ater bath.
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collected in a flask immersed in ice water. Excess H20 2 w as removed by 
passing the reaction mixture through a column (10 x 1.5 cm) packed with 
m anganese oxide (Mn02); the resulting solution containing a large excess of 
alkali w as stored at -20 °C for periods no longer than tw o weeks. The use 
of M n02 in the removal of excess H20 2 resulted in loss of peroxonitrite; this 
decomposition of peroxonitrite has previously been attributed to  M n02 
catalyzing a reaction with H20 2 to give nitrite as a product (110). Therefore, 
our peroxonitrite solutions were contaminated with nitrite and nitrate ions, 
but no attem pts for further purification were made. Other investigators had 
unsuccessfully attempted such purification in the past using several different 
techniques and observed that decomposition of peroxonitrite was 
unavoidable (111). Peroxonitrite solutions form a deep yellow top layer by 
freeze fractionation, aliquots obtained from this top layer were used in the 
experiments. The concentration of peroxonitrite in the top layer, determined 
spectrophotometrically at 302 nm using an extinction coefficient of 1670 
M'1 cm '1 (111), w as typically about 0 .1 0  ± .02 M. A cell containig 
previously decom posed peroxonitrite in phosphate buffer w as used as 
reference to correct for interference by other compounds (e.g. nitrite) 
absorbing at 302  nm.
Decomposition of Peroxonitrite. Peroxonitrite decomposition was 
followed at 25 °C in 0 .1-0 .5  M sodium phosphate buffer for at least three 
half-lives by measuring absorbance changes at 302 nm every 0.1 s after
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addition of peroxonitrite (0.25 to 3 .00  mM) to a therm ostatted  cell. The pH 
of the solutions w as measured at the end of each experiment. First order 
kinetics were observed over at least three half-lives.
Exposures. Solutions of a1PI (125 /yg/mL, 2 .4  //M using a MW of 
52 kDa) were incubated with peroxonitrite (1 to 2 mM) in 0.1 M or 0 .5  M 
sodium phosphate buffer under constant stirring for 2 to 12 hr at 25 °C in 
dark glass vials. Other additives were added as indicated in table legends. 
The pH of solutions w as measured at the end of each incubation period and 
found to be 10.4-11.5  ±  0 .5  using 0.1 M buffer, and 7 .40  ± 0 .05  using 
0 .5  M buffer. Exposures of the synthetic peptide, MER-10, were carried out 
in a 2:1 (mM) molar ratio of peptide:peroxonitrite in 0.1 M phosphate buffer 
with incubation periods of 24  hr at 37 °C. Protein or peptide samples 
incubated and treated under the same conditions as peroxonitrite-treated 
samples but in the absence of peroxonitrite were used as controls.
Elastase Inhibition Assay. Assays for inhibitory activity were 
performed by measuring the decrease in elastase enzymatic activity resulting 
from preincubation for 5 min at 25 °C with native or peroxonitrite-treated 
a1PI. Elastase activity w as measured according to  the method described by 
Bieth et al. (77) and has already been described in the Experimental section 
of Chapter I.
Amino Acid Analysis. Refer to Experimental section of Chapter I.
HPLC. The products of the reaction betw een peroxonitrite and
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MER10 were isolated by semipreparative reverse-phase HPLC in a Econosil® 
C18 10U Alltech column (10 //m, 250x10 mm) (Alltech Associates, Inc., 
Deerfield, II). The mobile phase consisted of a ternary system  of water, 
acetonitrile, and /so-propanol; all solvents contained 0 .1%  trifluoroacetic 
acid. The com ponents of the  reaction mixture were separated using a flow 
rate of 3 mL/min and an initial eluent composition of 80%  water, 15% 
acetonitrile and 5%  isopropanol which w as linearly increased to 95%  
acetonitrile and 5%  /so-propanol over a period of 45 min. Isolated fractions 
were evaporated under vacuum and their molecular weights and NMR 
spectra  obtained as described below. Two major fractions were collected 
from the  reaction of MER10 and peroxonitrite comprising 65%  and 35%  of 
the starting material.
NMR Analysis of MER10. The concentration of the peptide samples, 
determined from peak areas obtained during the HPLC isolation, was 
estimated to be 1.2 and 0 .8  mM. Refer to the Experimental section of 
Chapter I for further details.
Time-of-Flight MS Analysis. Refer to the Experimental section of 
Chapter I.
RESULTS
Decomposition of Peroxonitrite. The kinetics of decomposition of
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peroxonitrite to nitrate is perhaps the most thoroughly studied chemical 
a spec t of this compound (101 ,102 ,111-116). In our case , the purpose of 
measuring the rates of decomposition of peroxonitrite w as to estimate the 
duration of incubation times of peroxonitrite with either o r l P I  or MER10 
necessary  to allow complete decomposition (or disappearance) of 
peroxonitrite. Due to the simplicity of the method utilized in these  
m easurem ents, we were limited to following the decay of peroxonitrite 
within the pH range of 7 .00  to  10.75. The disappearance of the 302  nm 
band due to peroxonitrite is too fast a t pH values below this range.
The kinetics for the decomposition of peroxonitrite were fitted to a 
first order reaction equation by nonlinear regression. A typical plot 
generated by following the decay of absorbance at 302  nm is show n in 
Figure II.2. We observe first-order kinetics over at least three-half lives as 
previously reported (111,113). The dependence of the apparent first-order 
rate constan t on pH is shown in Figure II.3. It has been proposed (111,113) 
tha t  this pH dependence is consistent with the  reaction sequence  show n in 
eqs 1 and 2, and tha t this process can be described by eq 3, where I<hA is 
the first-order constant for the decomposition of peroxonitrous acid 
(HOONO), and Ka is the ionization constant for peroxonitrous acid.
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FIGURE 11.2. Decomposition of Peroxonitrite. Typical curve obtained for the 
decomposition of peroxonitrite by following the change in absorbance at 302 
nm at 25 °C in 0.1 M phosphate buffer (pH 7.80). The curve drawn 
through the  data points is the nonlinear regression fit obtained using the 
equation: y = a x exp (-bt).
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FIGURE 11.3. The Effect of pH on the Apparent Rate Constant of 
Peroxonitrite Decomposition. Apparent rate constants  for the decomposition 
of peroxonitrite were fitted to  a first order reaction equation by nonlinear 
regression. The pH of the  solutions w as determined at the  end of each run. 
Each data point represents the average of tw o to four determinations. Error 
bars are show n only where they are larger than symbols.
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0 N 0 0 ”+ H+  ------ — ^  ONOOH M)
HOONO  > N 03‘ + H+ (2)
kob. = (knAx [H+])/([H+] +  Ka) (3)
A plot of 1/kob8 against 1/[H+] is linear (Figure 11.4), and gives values 
of 0 .4 4  ± 0 . 1 0  s"1 and 7.1 ±  0 .3  for k„A and pKa, respectively. At pH 7 .4  
this rate constan t value corresponds to a half-life of 4 .6  s, and a t  pH 1 0 .4  to 
a half-life of 50 min. These results are consistent with recent studies by 
Beckman et al. (101,102) who determined the rate constan t k ^  for the  
decay  of peroxonitrite and the pKa of peroxonitrous acid at pH 7 .4  and 
37  °C to  be 0 .65  ±  0 .0 5  s '1 and 6.8, respectively.
Decomposition of peroxonitrite in the Presence of Methionine. We 
observe tha t  when peroxonitrite is incubated in the  presence  of methionine 
the  initial rate of d isappearance of the 302 nm band due to peroxonitrite 
increases linearly with the  concentration of Met added (Figure 11.5 and Table 
II.I). Methionine sulfoxide or methionine sulfone, the  tw o possible oxidation 
products formed in this reaction, do not absorb significantly at 3 02  nm, and 
therefore do not interfere with these  m easurem ents.
Methionine promotes the rate of disappearance of peroxonitrite a t pH 
values larger than the  m easured pKa for peroxonitrous acid which sug ges ts  
th a t  the  reacting species is predominantly peroxonitrite ion rather than  its
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FIGURE 11.4. Determination of the Equilibrium Constant and Pseudo-First 
Order Rate Constant for the Decomposition of Peroxonitrous Acid. Plot of 
1/kob. against 1/[H+] using the expression = (k ^  x [H+])/([H+] + Ka).
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FIGURE 11.5. Peroxonitrite Decomposition in the Presence of Methionine. 
Initial rates of decomposition of peroxonitrite as a function of methionine 
concentration at pH 8 .8 . Error bars are only show n where larger than 
symbols. Each data  point represents the average of tw o determinations.
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TABLE ll.l. The Effect of Methionine on the Initial Rates of Decomposition 
of Peroxonitrite\
Met (mM) peroxonitrite
(mM)
pH kobe x 10‘3 (s'1)
0 .0 0 .8 4 8 .8 9 ±  0
0 .25 0 .8 4 8.8 25 ± 2
0 .5 0 0 .84 8.8 45 ±  1
0 .75 0 .8 4 8.8 64  ±  1
1.00 0 .8 4 8 .7 81 ±  1
0 .0 0 1.68 10.7 0 .2  ±  0 .0
1.00 1.68 10.7 0 .6  ±  0 .0
“ Approximate initial rates of peroxonitrite decomposition were determined at 
25 °C in 0.1 M sodium phosphate buffer by measuring absorbance changes 
at 302  nm every 0.1 s after addition of peroxonitrite (0.25 to 3 .00  mM) to a 
therm ostatted  cell containing different concentrations of Met. The pH of the 
solutions w as measured at the end of each experiment.
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FIGURE 11.6. Inactivation of Alpha-1-PI as  a Function of Peroxonitrite 
Concentration. Alpha-1-proteinase inhibitor (125 jt/g/mL) w as exposed to 
different concentrations of peroxonitrite at 37 °C in phosphate buffer (pH 
10-11.5 ±  0.5), and assayed for anti-elastase activity as described in the 
Experimental Section. Each data point is the average of duplicate 
m easurem ents of tw o independent determinations.
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conjugated acid; these  results are shown in Table II.I.
Inactivation of Alpha-1-PI by Peroxonitrite. Peroxonitrite inactivates 
crIPI in a dose-dependent manner (Figure 11.6). At the lowest peroxonitrite 
concentration used, 170 /j M  (about 70:1 excess), a 24%  decrease  in EIC is 
observed. As sta ted  in the experimental section, solutions of peroxonitrite 
are contaminated with nitrite and nitrate ions, and possibly H20 2. Although 
most of the H20 2 is probably removed by treating the crude peroxonitrite 
with M n02, traces of hydrogen peroxide left after this treatm ent could 
oxidize the methionine residue in the active site of o1PI (Met358) causing its 
inactivation (40). In order to assure ourselves that o1PI is inactivated by 
peroxonitrite and not by either H20 2 or a mixture of nitrite and nitrate ions, 
o1PI w as incubated with peroxonitrite, an equivalent solution of 
peroxonitrite decomposed prior to addition, and a mixture of nitrite and 
nitrate ions. Figure II.7 show s that additon of 2 mM peroxonitrite causes 
complete inactivation, while an equivalent concentration of a decomposed 
peroxonitrite does not inactivate o1PI. Similarly, the anti-elastase activity 
of a1PI is not affected upon incubation with nitrite and nitrate ions. These 
results illustrate tha t inactivation of the protein is caused by peroxonitrite 
and not by either a mixture of nitrite and nitrate ions nor by H20 2 not 
removed by M n02. Moreover, Table II.II show s that addition of catalase 
provides minimum protection (ca. 9%) against inactivation of a1PI. About 
the sam e degree of protection observed with catalase is obtained with BSA
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FIGURE 11.7. Effect of Decomposed Peroxonitrite, Nitrate, and Nitrite Ions on 
the Anti-Elastase Activity of Alpha-1-PI. All solutions (final volume of 
250  //L) were incubated at 25 °C for 3 hr and contained 125 //g/mL o1PI,
2 mM peroxonitrite (■ ), or 0 .3  M nitrate + 0 .3  M nitrite (□ ), or 2 mM 
decom posed peroxonitrite (O) in 0 .5  M phosphate buffer (pH 7.4). The EIC 
of crlPI w as determined as described in the  Experimental Section. 
Decomposed peroxonitrite w as prepared by incubating it in buffer a t 4 0  °C 
until the absorbance band at 302  nm had disappeared. Uninhibited elastase 
(O) and untreated o1PI ( • )  are show n for comparison purposes. Error bars 
appear only where they are larger than symbols, and they represent the 
standard deviation of duplicate runs of tw o determinations.
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(ca. 4 .8% ), suggesting that catalase protects by a sacrificial role rather than 
by its catalytic activity, and tha t  H20 2 removal, after the  synthesis of 
peroxonitrite, is effective.
Peroxonitrite is stable in alkaline solutions (111) but has a pKa of 6 .8 
and decom poses rapidly after it is protonated. It has been proposed 
(102,115) tha t peroxonitrite decomposition generates a strong oxidant with 
reactivity similar to that of the  hydroxyl radical (HO- in eq 1), and N 02, also 
a radical and a strong oxidant.
To investigate if HO- is responsible for tne observed inactivation of 
o1PI by peroxonitrite, we added hydroxyl radical scavengers to the 
incubation mixtures; these  results are shown in Table II.II. Out of the HO- 
scavengers used, thiourea is the  most effective, affording complete 
protection against peroxonitrite-induced inactivation of o1PI. Benzoate and 
mannitol, also strong HO- scavengers, do not protect olPI significantly even 
in a 50-fold excess with respect to peroxonitrite. Urea, a relatively weak 
scavenger of HO-, also fails to protect a1PI. On the other hand, methionine 
which is not considered a specific scavenger of HO- completely prevents 
gtIP I  inactivation. Similar results are obtained under basic and physiological 
pH suggesting that the sam e mechanism of inactivation operates under both 
conditions.
Table II.Ill show s estimated rates of reaction betw een the hydroxyl
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TABLE 11.11. Protection by Hydroxyl Radical Scavengers and Catalase 
Against Inactivation of Alpha-1-PI by Peroxynitrous Acid*.
Compound Concentration 
in final system
(0 N 0 2](mM) % Protection1* 
(pH 10 .4 -11 .5 )
% Protection1* 
(pH 7 .4)
Catalasec 100 U/mL 2 0 .0 NDd
3 0 0  U/mL 1 ND 9 .2  ±  1.5
BSA 5.33  //g/mL 1 ND 4 .8  ±  0 .8
Methionine 20  mM 2 99 .6  ±  1.4 ND
25 mM 1 100 .0  ±  2 .8 ND
Thiourea 20  mM 2 9 9 .0  ±  0 .7 ND
20  mM 1 ND 9 9 .0  ±  0.1
50 mM 1 97.7  ±  0 .6 104 .0  ±  0 .0
Urea 50 mM 1 7 .0  ±  5 .0 4 .8  ±  2 .4
Benzoate 20 mM 1 ND 19.3 ±  5 .7
50  mM 1 10.0  ± 5 .2 15 .6  ± 2 .4
Mannitol 50  mM 1 11.8  ± 0 .5 10.9  ± 4 .8
a Reaction mixtures containing o1PI (125 //g/mL), added com pounds in the 
indicated concentrations, and peroxonitrite (1 to 2 mM) were incubated for 
periods of 3 hr (25 °C) in 500  mM phosphate buffer (final pH 7 .4 0  ±  .05) 
or 12 hr (25 °C) in 100 mM phosphate buffer (final pH 10.4  to 11.5). 
b Percent protection was calculated as 100x[(100 - %EICA)/(100-%EICB)], 
where "%EICA" is the EIC measured for d P I  plus peroxonitrite plus additive 
and "%EICb" is the EIC measured for e/1PI plus peroxonitrite only. Values 
are presented as average % protection ±  standard deviation calculated from 
duplicate runs of at least tw o independent experiments. 
c 100 U/mL catalase corresponds to 7.1 jwg/mL, and 300  U/mL to 
21 .3  //g/mL.
d ND stands for not determined.
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radical and different com ponents present in the  incubation mixtures. These 
calculations indicate that all scavengers used, except for urea, should 
effectively protect a1 PI against peroxonitrite-induced inactivation if HO1 
were the  inactivating species.
Oxidation of Methionine. Product analysis of the reaction betw een 
MER10 and peroxonitrite was conducted to gain some insight into the 
mechanism of inactivation of orl PI by peroxonitrite.
Figure 11.8 show s the PDMS spectra obtained for untreated MER10 
(Fig. II.8A), and for the two HPLC fractions isolated (see Experimental) from 
the reaction of MER10 with peroxonitrite (Fig. II.8B and 8C). The spectrum  
of MER10 show s two intense peaks with m asses of 1145 and 1167 
corresponding to the (M + H)+ and (M + Na)+ ions respectively, and a less 
intense peak of 1189 corresponding to the (M + 2Na)+ ion. Inspection of 
spectrum  8B suggests  that this HPLC fraction is unreacted peptide with 
m asses corresponding to the (M + H)+, (M + Na)+, (M + 2Na) + , and 
(M +  3Na)+ ions. Spectrum 8C indicates the addition of 16 m ass units to the 
molecular weight of MER10 and consists of four peaks with mass values of 
1160, 1182, 1205, and 1225 corresponding to the ions (MO + H)+,
(MO + Na)+, (MO + 2Na)+ and (M0 + 3Na)+, respectively6. We do not 
observe ions of lower molecular weight than that of MER10 in the PDMS
6 The notation (MO) indicates the molecular weight of 
MER10 (M) + 16 amu.
TABLE II.III. Rate Constants and Reaction Rates Between the Hydroxyl 
Radical and Various Components Present in Incubation Mixtures of 
Alpha-1-PI and Peroxonitrite.
Reactions Rate Constants* 
(L mol"1 s‘1|
Concentration 
(mol L"1)
Reaction Rate 
(s'1)
HO1 + Protein 1 0 " 2 .3  x 10‘fi 2 .3  x 10fl
HO- + Hydrogen 
phosphate
1.5 x 106 0 .4 6.1 x 104
HO- + Dihydrogen 
phosphate
~ 2  x 104 0.1 1.9 x 103
HO' + Thiourea 3 .9  x 10s 2 .0  x 10'2 7 .8  x 107
HO' + Benzoate 5 .9  x 109 5 .0  x 10'2 3 .0  x 108
HO' + Mannitol 1.7 x 109 5 .0  x 10'2 8 .5  x 107
HO' + Urea 7 .9  x 106 5 .0  x 10'2 4 .0  x 104
HO' + Methionine 8 .3  x 1Q9 2 .0  x 10'2 1.7 x 108
8 All rates constants  (pH 7, 25 °C) were obtained from reference (117).
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FIGURE 11.8. M ass Spectra  of the Products Isolated from the Reaction of 
Peroxonitrite with MER10. HPLC fractions obtained from the reaction 
be tw een  peroxonitrite and MER10 are designated using the sam e 
nomenclature of Table II.IV. A: MER10; B: HPLC fraction 1B; C: HPLC 
fraction 1C. All spectra  were obtained on a JMCf Plasma Desorption Time-of- 
Flight Bio-Ion 20  m ass spectrom eter.
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spectra  of either fraction (1B and 1C) indicating that fragmentation of the 
peptide does not occur upon reaction with peroxonitrite. Similarly, no 
evidence of nitration which would give a molecular weight of 1190 amu 
(1144 + 46) is observed in Fig. II.8. The most probable site for nitration in 
MER10 is the phenyl ring of phanylalanine. Some low intensity peaks in 
spectra 8B and 8C are not labeled since they are also present in the 
spectrum of MER10 (Fig. II.8A), and therefore are considered of no 
relevance. The presence of Na in these  samples is probably due to the fact 
tha t peroxonitrite solutions are highly contaminated with the alkali (see 
preparation of peroxonitrite in Experimental Section).
The amino acid analysis of the HPLC fractions isolated from the 
reaction of MER10 with peroxonitrite is presented in Table II.IV. The amino 
acid composition of fraction C again show s no evidence of peptide cleavage 
or modification of any other residue except for complete oxidation of 
methionine to methionine sulfoxide. These results are in agreem ent with the 
M + 16 peak detected by PDMS for fraction 1C (Fig. II.8C). Fraction 1B 
show s about 10% oxidation of total methionine, suggesting tha t this 
fraction is mostly composed of the  unreacted peptide with a small 
contamination of the oxidized peptide. In agreem ent with this explanation 
the PDMS spectrum  of this fraction (Fig. II.8B) does not show  the presence 
of the oxidized peptide or of any smaller molecular weight peptides, 
indicating tha t this fraction is mainly composed of unreacted MER10.
TABLE II.IV. Amino Acid Composition of MER10 Exposed to Peroxonitrite
Residue MER10 Product 1B Product 1C
GLU 1 0 .5 ± 0 .4 1 0 .2 ±  1.2 1 0 .4 ± 0 .7
SER 9 .9 ± 0 .6 8 .8 ± 0 .8 8 .6 ± 0 .3
MET 1 0 .4 ± 0 .7 7 .6 ± 0 .0 0 .4 ± 0 .3
VAL 9 .8 ± 0 .4 1 0 .5 ± 0 .3 1 0 .3 ± 0 .2
METSOb 0.1 ± 0 .1 1 .6 ± 0 .5 8.5 ± 0 .6
ILE 1 0 .0 ± 0 .1 1 0 .5 ± 0 .2 1 0 .3 ± 0 .2
PHE 1 0 .0 ± 0 .1 1 0 .2 ± 0 .4 9 .8 ± 0 .6
LYS 10.5 ± 0 .5 1 0 .4 ± 0 .5 9 .2 ± 0 .9
PRO 2 9 .3 ± 3 .0 3 0 .2 ± 0 .5 32 .5  ± 2 .1
“ Residue am ounts expressed as  % mol ±  s.d . of duplicate runs of tw o 
independent experiments.
b Methionine sulfoxide w as determined by the  cyanogen bromide method 
(see experimental).
Further confirmation for the oxidation of methionine to  methionine 
sulfoxide (MetSO) as the major product of the reaction betw een MER10 and 
peroxonitrite is revealed by 1H NMR7. Figure II.9 show s the one­
dimensional NMR spectra (1D NMR) of fraction 1C and MER10. The most 
noticeable change in the  spectrum  of fraction C (panel A in Fig. II.9) is the 
disappearance of the sharp singlet a t 2 .00  ppm due to the e-CH3 moiety of 
Met observed in MER10. Instead, a lower field resonance line at 2 .65 ppm 
is observed; this signal corresponds to the protons in the e-CH3 group of 
MetSO confirming sulfur oxidation. The rest of the protons in MetSO (/?-CH2 
and k-CH2) are also shifted to lower field positions compared to the Met 
signals in MER10. The aromatic protons of the phenylalanine residue 
(inserts in Fig. II.9) in fraction 1C show  the sam e chemical shift and pattern 
of those  corresponding to Phe in MER10, indicating absence of nitration of 
this residue in the product. These results also suggest that hydroxylation of 
the benzene ring by peroxonitrite, as previously reported (116), does not 
occur in the major product isolated from this reaction.
The resonance lines corresponding to the o-protons in these  peptides 
(except for Val oH) are not show n in the 1D NMR spectra displayed in Fig.
II.9. The signals due to both 0H  and oH protons of most residues are poorly 
resolved in 1D spectra. The assignment of these  resonances is enabled
7 Assignments for all the resonances observed in MER10 have 
been accomplished by the  use of COSY and RELAYED COSY 
experiments show n in Chapter I.
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FIGURE 11.9. 'H 1D NMR Spectra of MER10 and the Major Product Isolated 
from the Reaction with Peroxonitrite. Amino acids are represented using 
the  single-letter code. Panel A show s the spectrum  of the  major product 
resulting from the reaction betw een MER10 and peroxonitrite; panel B 
sho w s the  spectrum  of MER10. Inserts in both panels show  the resonance 
lines of the  aromatic protons of Phe. Spectra were collected in D20  at 
25 °C and chemical shifts are relative to  TSP.
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through the use of a two-dimensional COSY experiment. Figure 11.10 show s 
an expansion of the COSY spectra obtained from fractions B and C. The 
cross peaks in this region result from interactions between the arH and /?H 
protons of all ten residues, and the /?H and yH, and <SH and S'H of the three 
prolyl residues. Most spin system s in this peptide show  a degeneracy in the 
tw o aH-0H cross peaks. For example; the tw o aH-f3H cross peaks of Ser are 
overlapped and appear as a single cross peak since both f3H protons have 
nearly identical chemical shifts and the fiH-jS'H cross peak is covered by the 
diagonal. However, this degeneracy does not hinder the interpretation of the 
spectra.
The COSY spectra in Fig. 11.10 confirm the observations made from all 
product analyses discussed above. The COSY spectrum of fraction 1C only 
differs from that of MER10 (not shown) in that the oH-yffH cross peak of Met 
is not present and instead a cross peak due to  the aH-fiH protons in MetSO 
is observed. The spectrum of fraction 1B show s an oH-/?H cross peak 
characteristic of Met indicating, as sta ted above, this is predominantly 
unreacted MER10. Again no indication of nitration or hydroxylation of the 
Phe residue is observed in these  spectra.
We observe that when MER10 is exposed to peroxonitrite in the 
presence of a large excess of dimethyl sulfoxide (DMSO) no oxidation of Met 
to MetSO occurs. DMSO is a powerful hydroxyl radical scavenger, it 
interacts with HO- to produce methyl radicals (’CHa) which ultimately form
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FIGURE 11.10. Expansion of COSY Spectra Obtained from Fractions 1B and 
1C Isolated from the  Reaction of MER10 and Peroxonitrite. NMR spectra  of 
fractions C (panel A) and B (panel B) were collected in D20  a t 25  °C. The 
cross peaks show n in this region result from interactions be tw een  orH and 0H  
protons in all ten  residues of the  peptide, /?H and yH, and <5H and 6 H  of the 
prolyl residues. Amino acids are represented using the  single-letter code.
methane by hydrogen abstraction or formaldehyde (118) after reaction with 
molecular oxygen and subsequent decomposition. On the other hand,
DMSO can also be oxidized by strong oxidants such as HOCI and H20 2 
(119).
We conducted a simple experiment in order to  determine whether 
DMSO prevents oxidation of the methionine residue in MER10 by scavenging 
HO' or by being oxidized to the sulfone reacting directly with peroxonitrite. 
DMSO (0.2 M) w as allowed to  react with peroxonitrite (2.5 mM) in 
deuterium oxide (D20) at pH 10.5 in an NMR tube, and the reaction mixture 
w as analyzed by NMR after 30  min, 1 hr, and 24  hr. The NMR spectra  
obtained after these  intervals show  a singlet a t 2 .9  ppm indicating that 
peroxonitrite oxidizes dimethyl sulfoxide to dimethyl sulfone. At this pH, we 
do not detect any resonance lines suggesting formation of formaldehyde.
DISCUSSION
There is ample evidence in the literature indicating that peroxonitrous 
acid (0 N 0 2H), the protonated form of peroxonitrite, rapidly and 
quantitatively isomerizes to nitric acid (104 ,111-114 ,120). However, there 
is confusion as to  whether the mechanism of isomerization proceeds by 
homolysis of the 0 - 0  bond with the formation of the hydroxyl radical and 
nitrogen dioxide as intermediates (eqs 4  and 5), or via an intramolecular
rearrangem ent without the  production of radical intermediates (eq 6).
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0N 00H   ^ [N02# +»OH] (4)
[N02»+*0H]  > HONOz (5)
O N O O H -------------------- > HONOj, (6)
Halphenny and Robinson (116) first proposed a radical mechanism 
based on the observations th a t  peroxonitrite at pH 0 .5 -1 .2  hydroxylated 
aromatics in very low yields and also initiated the polymerization of methyl 
acrylate. This m echanism of isomerization through radical intermediates has 
been opposed by Hughes and Nicklin (111) who calculated the activation 
energy for the isomerization of peroxonitrite to be 12.5 kcal mol'1, a value 
very different from the  usual one calculated for 0 - 0  homolyses 
(e.g. 30-40  kcal mol'1).
Our results suggest  tha t peroxonitrite inactivates ct1 PI by oxidizing the 
Met residue in the  active site (40), and that the oxidizing agen t m ost 
probably is peroxonitrite and not H O \
Methionine prom otes the  decomposition of peroxonitrite at pH values 
above the  calculated pKa for peroxonitrous acid indicating th a t  peroxonitrite 
ion reacts with Met, and not HO* or N 0 2 which would only form through the
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decomposition of peroxonitrous acid (eq 4). Under basic conditions 
(e.g. pH 10 to 11.5) peroxonitrite ion is stable (111), and production of HO' 
and N 02 is not pertinent since peroxonitrous acid is mostly dissociated (pKa 
6 .8  ±  0.3). We observe tha t peroxonitrite inactivates a1 PI in a pH range of 
10 .0-11 .5  again suggesting that the anion reacts with o1PI causing its 
inactivation. Under both physiological and basic pH conditions, benzoate 
and mannitol do not prevent a lP I  inactivation by peroxonitrite confirming 
that the oxidizing agent is not HO'.
It has been observed that HO' reacts with proteins causing gross 
structural modifications and spontaneous fragmentation (121-124).
However, product analysis of the reaction between peroxonitrite and MER10 
by PDMS indicates that fragmentation of the  peptide does not occur at 
significant levels. Furthermore, we do not observe either nitration or 
hydroxylation of phenylalanine in the major product isolated from the 
reaction betw een MER10 and peroxonitrite. Both nitrated and hydroxylated 
peptides would be expected to form as a result of the reaction of N 02 or HO' 
with the Phe residue in MER10.
We observe that thiourea, a powerful HO' scavenger, affords a1PI 
complete protection against peroxonitrite-induced inactivation. However, 
this observation does not unequivocally confirm the presence of HO' since it 
has been show n that thiourea is not specific as a scavenger of HO' (119) 
and can be oxidized, for example, by H20 2 (125). The protection observed
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with thiourea and Met, both present in large excess with respect to o1PI, 
probably arises because these  compounds are being oxidized and therefore 
depleting peroxonitrite before oxidation of the protein takes place. This 
assumption w as verified by the  observation tha t  peroxonitrite reacts with 
DMSO at basic pH to  form primarily the sulfone. We do not de tect other 
oxidation products, such as formaldehyde, which would indicate that DMSO 
has reacted with HO-. This line of reasoning leads us to speculate tha t urea, 
mannitol and benzoate do not protect o1PI since they cannot be easily 
oxidized.
CONCLUSION
Our results indicate that at physiological pH peroxonitrite is a powerful 
oxidant8 on its own without the requisite of forming HO- (or N 0 2) through 
the decomposition of peroxonitrous acid as previously suggested  (102). We 
show  that peroxonitrite is capable of oxidizing methionine residues in 
proteins such as o1PI. The oxidation of Met to  MetSO has been reported to 
cause loss of biological activity in a wide variety of proteins (126,127). The 
methionine residue, which upon oxidation renders o1PI inactive, is situated 
in the active inhibitory site of the protein (Met358-Ser359) (40). This region of
8 An oxidation potential of E°' = 1.5 v has been estimated for the 
reduction of 0 N 0 2 to N 0 2 (W.H. Koppenol, unpublished results).
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o1PI is a highly stressed  loop protruding from the protein and is, therefore, 
very accessible (128). We suggest that, due to its relatively small size, 
peroxonitrite could also oxidize less accessible methionine residues in other 
proteins. In fact, peroxonitrite ion w as recently show n to mediate the 
oxidation of sterically hindered sulfhydryl groups in albumin (101).
In addition, we suggest tha t NO, present in cigarette smoke, could 
participate in the development of emphysema and other lung diseases 
related to cigarette smoking (60,129) by a previously unconsidered 
pathway. Cigarette smoke could increase transient concentrations of 
cellularly-produced NO (105,106) which upon reaction with PAM-derived 
superoxide (99,100), already increased in smokers, forms the strong oxidant 
peroxonitrite. As we have shown, peroxonitrite could oxidize a1PI, leaving 
the lung susceptible to an unopposed proteolytic attack on its extracellular 
matrix.
CHAPTER III. Release of Iron from Ferritin by Aqueous Solutions of 
Cigarette Smoke
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ABSTRACT
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This study dem onstra tes the ability of aqueous solutions of cigarette 
smoke to  reduce iron and cause  its release from ferritin. SOD increases the 
rates of iron release with the less filtered smoke solutions, but has no effect 
on the rate of iron release caused by aqueous solutions of gas-phase 
cigarette smoke. Faster rates of iron release are observed under anaerobic 
conditions and the reducing power of the cigarette smoke solutions is 
prolonged when incubated in argon. Hydroquinone and catechol, tw o of the 
major polyhydroxybenzenes in cigarette smoke, increase in concentration in 
the smoke as this is subjected to  less filtration. Higher concentrations of 
these  benzenediols correlate with higher rates of iron released from ferritin. 
Concomitant with iron release, depletions of amino acids in ferritin are 
observed. Depletion of histidine is partially prevented by 
bathophenanthroline sulfonate and mannitol, while lysine and arginine 
depletions remain unaffected. These observations suggest that cigarette 
smoke com ponents react directly with these  amino acid residues in ferritin. 
Cigarette smoke-induced release of iron could alter iron metabolism in the 
lungs of chronic smokers and contribute to  the increase in the  total oxidative 
burden on the  lungs of smokers.
INTRODUCTION
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Cigarette smoking has been implicated in a variety of lung diseases, 
such as emphysem a and lung cancer (18,129), but the basic mechanisms by 
which tobacco smoke causes disease are still not well understood.
Prolonged exposure to cigarette smoke also causes inflammation in the 
lower respiratory tract, a condition associated with larger numbers of 
pigment-laden macrophages found in the bronchiole, alveolar ducts, and 
alveoli of smokers (60). It has been shown that the pulmonary alveolar 
macrophages (PAM) of smokers contain increased amounts of iron and 
ferritin (57). The reason for these  increased levels of iron and ferritin in the 
PAM of chronic smokers is not known. McGowan and Henley (130) have 
suggested  that the majority of this iron is insoluble and seem s not to be 
associated with the iron storage protein ferritin. Also, Qian and Eaton (131) 
recently show ed that cigarette smoke solutions were able to reduce salts 
containing ferric ions and to bind the resulting ferrous ions. Preliminary 
electron spin resonance studies of lung tissue from smokers suggest iron 
accumulation that is proportional to the dark pigmentation of the lung (132).
These considerations prompted us to study the ability of aqueous 
solutions of cigarette smoke to release iron from ferritin, the principal source 
of physiological iron. Cigarette smoke contains high concentrations of 
polyhydroxybenzenes (1,18,19) with reduction potentials (133) lower than
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ferritin (134); these  compounds could theoretically reduce and release iron 
from ferritin.
In the studies reported here we have investigated the ability of 
aqueous solutions of cigarette smoke to release iron from ferritin, and the 
effects of SOD and catalase on this release. We also report the effect of 
aqueous solutions of cigarette smoke on the structure of ferritin.
EXPERIMENTAL
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Chemicals. Bathophenanthroline disulfonic acid, 4,7-diphenyl-1,10- 
phenanthrolinedisulfonic acid, o/tho-phthalaldehyde, 1,4-benzenediol 
(hydroquinone), 1,2-benzenediol (catechol), diethylenetriaminepentaacetic 
acid (DTPA), ethylenediaminetetraacetic acid (EDTA), mannitol, amino acid 
standard solution (2.5 mM, 0.1 N HCI), D-glucose, and 1,4-dithiothreitol 
were all purchased from Sigma Chemical Co. (St. Louis, MO) and used 
without further purification. Hydrochloric acid (6N) w as purchased from 
Pierce (Rockford, II). Research cigarettes (1R1 and 2R1F) were purchased 
from the University of Kentucky, Tobacco and Health Research Institute, 
stored at -20°C , and humidified in a desiccator over saturated ammonium 
nitrate at room temperature for at least 24  hr prior to use. Chelex-100® 
resin w as purchased from Bio-Rad Laboratories (Richmond,CA). All other 
chemicals were of reagent grade, and used without further purification.
Enzymes. Bovine liver catalase (EC 1 .11.1 .6), bovine erythrocyte 
copper-zinc superoxide dismutase (EC 1.15.1.1), and glucose oxidase (EC 
1.1.3.4) were all purchased from Sigma Co. In order to remove adventitious 
iron, glucose oxidase w as incubated with 10 mM DTPA for 1 hr in ice, 
ultrafiltered and washed with tw o volumes of 250 jjL of deionized distilled 
w ater in a Millipore Ultrafree-PF filter unit with a molecular weight cutoff of 
10 ,000 .
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Ferritin Preparations. Aliquots of type I horse spleen ferritin, 
purchased from Sigma, were ultrafiltered, washed with tw o volumes of 
deionized distilled water, and redissolved in 0.1 M phosphate buffer (pH 7.4, 
Chelex-treated) to give a final concentration of 30  mg/mL. This solution 
w as stored at 4 °C  for periods not longer than 72 hr. The purpose of this 
treatm ent is to eliminate unconfined iron from ferritin solutions. A more 
rigorous purification of ferritin w as not pursued since the aqueous solutions 
of cigarette smoke contain traces of iron themselves. Total iron content of 
ferritin, determined as described by Brumby and Massey (135), w as found to 
be 4 .6 9  //mol Fe/mg protein.
Preparation of Cigarette Smoke Aqueous Solutions. Using the puff 
protocol described elsewhere (53), the smoke from 1R1 or 2R1F research 
cigarettes w as bubbled through phosphate buffer (0.1 M, pH 7.4, Chelex- 
treated) contained in a test-tube immersed in an ice-water bath. No filter 
w as used to prepare solutions termed "whole-smoke solution”, while those 
termed "filtered-smoke solution” were prepared by passing the smoke 
through the filter tip that 2R1F cigarettes contain. Solutions termed "gas- 
phase solutions" were prepared by smoking 1R1 cigarettes through two 
Cambridge filters. All solutions were prepared by bubbling the smoke of 1 
cigarette (ten 35-mL puffs) per 100 j jL  of buffer. All smoke solutions used 
were prepared immediately before experiments unless otherwise indicated.
Gel Electrophoresis. Aliquots (25 //g) of ferritin solutions similar to
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those  used for iron release experiments were subjected to native 
electrophoresis on a 5 .5%  acrylamide gel at 30  mA for approximately 3 hr at 
25 °C. After electrophoresis, gels were removed and stained with 
Coomasie brilliant blue R-250 for one hour, and then allowed to destain for 
24  hours in destaining solution (5% methanol, 7% glacial acetic acid, and 
2%  glycerol).
Amino Acid Analysis. Ferritin samples (125 /jq aliquots) were 
incubated with solutions of cigarette smoke for 12 hr at 3 7°C  and 
hydrolyzed with 6 N HCI at 110°C  for 24 hr in vacuo. Amino acids were 
separated and quantitated by HPLC in an AminoQuant® column (Hewlett- 
Packard) using o-phthalaldehyde precolumn derivatization according to 
Schuster and Apfel (78). Analysis of proline, cysteine, and tryptophan was 
not performed. Oxidation of methionine to methionine sulfoxide was 
determined by the method described by Shechter et at. (79). Briefly, 
lyophilized protein samples were dissolved in 80%  formic acid and allowed 
to  react with cyanogen bromide (100 mM) for 24  hr at room temperature.
The reaction w as stopped by addition of an equal volume of water, frozen 
and lyophilized. The cyanogen bromide peptides were hydrolyzed as 
described above but in the presence of 13 mM 1,4-dithiothreitol.
Iron Release. Initial rates of iron release were measured 
spectrophotometrically using bathophenanthroline disulfonate as metal 
chelator essentially as described by Thomas and Aust (136). Incubation
mixtures (1 mL final volume) contained 1 mM bathophenanthroline
disulfonate and 750  p q  of ferritin in 0.1 M phosphate buffer (pH 7.4,
15 m M  NaCI, Chelex-100® treated). Catalase and SOD solutions were
added as indicated in figure legends. Reactions were started by the  addition
of 100 p i  of smoke solution or benzenediol. The change in absorbance was
measured continuously at 530  nm for the first 20  minutes using a double
beam spectrophotometer. A cuvette  containing ferritin, bathophenanthroline
and added enzymes (catalase or SOD) but lacking cigarette smoke solution
or hydroquinones, w as used as reference. The amount of ferrous iron
released from ferritin w as calculated using a molar extinction coefficient of 
-1 -12 0 .6 6  mM cm obtained from a calibration curve using ferric sulfate 
reduced with a 10% solution of thioglycolic acid. For anaerobic 
m easurem ents all solutions were purged with argon, and, before addition of 
the  smoke solution, incubation mixtures were purged again with argon 
through a capillary glass tube inserted in the UV cell. In order to scavenge 
remaining oxygen, glucose oxidase and glucose were always added along 
with catalase to  both sample and reference cuvettes.
Iron Incorporation. All studies were conducted at pH 7 .0  in 
0.1 M HEPES [4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid] buffer 
according to  the method of Collawn et al. (137) with only minor changes. 
Briefly, 4 .5  mL of a solution of ferritin (0.1 mg/mL) in buffer w as  placed in a 
constan t tem perature water bath at 14°C, and allowed to equilibrate. A
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solution of ferrous ammonium sulfate (0.5 mL, 10 mM) dissolved in 
deairated water w as added and mixed vigorously. Aliquots (1 mL) were 
taken a t  1 minute intervals and added to Eppendorf tubes containing 0 .3  g 
of Chelex-100®. Samples were vortexed for 4  minutes and needle holes 
were punched in the bottom of the tubes. The perforated Eppendorfs were 
placed in larger te s t  tubes and centrifuged in a bench-top centrifuge for 4  
minutes. The eluted ferritin solution, free of Chelex-100®, w as then 
collected and its absorbance measured at 310  nm in Hewlett Packard 8 4 5 1 A 
Diode Array spectrophotometer; HEPES buffer w as used as  reference. The 
time of reaction w as taken as the  period elapsed betw een the addition of 
iron and the addition of the reaction mixture to Chelex-100®.
HPLC. A) By electrochemical detection: Aqueous solutions of 
cigarette smoke were separated using a Hewlett-Packard CDS (5 //m,
200x2.1 mm) (Hewlett-Packard Co., Avondale, PA) reverse phase column. 
The electrochemical detector consisted of a Model 5100A Coulochem® 
electrochemical detector (ESA, INC. Bedford, MA), a dual electrode 
analytical cell Model 5010  (ESA) consisting of two porous graphite in-line 
working electrodes with associated reference and counter electrodes, and a 
guard cell Model 5020  (ESA) placed before the column. Constant potentials 
of + 3 5 0  mV and + 4 0 0  mV were applied to  the working electrodes of the 
analytical and guard cells, respectively. The mobile phase consisted of a 
binary system  of water and methanol; both solvents contained 10 mM
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NaCI04. With a flow rate of 0 .5 0  mL/min, 5 y\- aliquots of smoke solution 
were injected onto the column and eluted with 10% MeOH. After 6 min the 
percentage of methanol was linearly increased to 100%  over 35 min. 
Response factors used for quantitative analysis of hydroquinone and 
catechol were calculated from calibration curves obtained using authentic 
compounds.
B) By UV detection: Aqueous solutions of cigarette smoke were 
separated in a Hypersil ODS column (200 x 4 .6  mm) connected to a 
Hewlett Packard HPLC model 1090M equipped with a diode array detector 
and an automatic injector. The eluent consisted of water and acetonitrile 
with an initial composition of 3%  acetonitrile which w as linearly increased to 
50%  acetonitrile over 12 min at a constant flow rate of 1.0 mL/min. The 
column w as washed with 100%  acetonitrile for 20 min after each injection 
(15 //L). After separation com ponents were detected using four 
wavelengths (230, 254, 280 and 300  nm), and the UV spectra of peaks in 
smoke solutions were compared to those obtained in chromatograms of 
authentic compounds. All solvents used were HPLC grade and filtered 
through a 0 .3  //m filter prior to use.
RESULTS
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Release of Iron from Ferritin by Aqueous Solutions of Cigarette 
Smoke. When ferritin is incubated with aqueous solutions of cigarette 
smoke, iron is reduced and mobilized from the protein core. Table III.I 
show s initial rates of iron release, measured spectrophotometrically under 
aerobic conditions. In the absence of ferritin none of the cigarette smoke 
solutions form significant amounts of bathophenanthroline-Fe complex (data 
not shown). Lines 1, 4  and 7 suggest the amounts of ferrous iron released 
increase as the smoke is subjected to less filtration (see experimental for 
smoke solution preparations). The rates of iron release depend on the 
amounts of all three types of smoke solution (Figure III. 1 A), and on the 
concentration of ferritin (Figure III. 1B; data only show n for filtered-smoke 
solution). Figure III. 1A show s that the rates of iron release for the different 
solutions of cigarette smoke increase over the range of smoke solution 
concentrations used in the order gas-phase <  filtered < whole smoke.
To determine whether superoxide participates in the reductive 
mobilization of ferric iron by cigarette smoke solutions, SOD w as included in 
the incubation mixtures. SOD does not affect the rate of iron release when 
the reaction mixture contains gas-phase solution (line 3, Table III.I). 
However, for both filtered and whole smoke solutions, rates of iron release
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TABLE III.I. Aerobic Release of Iron from Ferritin by Aqueous Solutions of 
Cigarette Smoke*.
Entry
no.
Smoke
Solution15
Additions nmol Fe Reduced/min 
per mg Ferritin
1 Gas None 0 .25 ±  0.01
2 Gas Catalase 0 .27 ±  0 .02
3 Gas SOD 0.27 ± 0.01
4 Filtered None 0 .89 ± 0 .05
5 Filtered Catalase 1.15 ±  0.01
6 Filtered SOD 1.88 ± 0 .07
7 Whole None 1.95 ± 0 .17
8 Whole Catalase 2 .56 ± 0 .27
9 Whole SOD 4 .69 ± 0 .26
* Reaction mixtures (final volume 1mL) contained ferritin (750 pg), the 
smoke from one 1R1 or 2R1F cigarette blown into 100 pL of buffer (see 
Experimental section), bathophenanthroline sulfonate (1 mM), SOD (500 
units) or catalase (500 units) in 15 mM NaCI, pH 7.4. Reactions were 
initiated by addition of smoke solutions and absorbance w as measured 
continuously at 530  nm during the first 20  min.
b "Gas" refers to solutions of cigarette smoke from 1R1 cigarettes passed 
through tw o Cambridge filters, "filtered" smoke solution from 2R1F 
cigarettes filtered with the self-contained filter tips, and "whole" to solutions 
of unfiltered smoke from 1R1 cigarettes.
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FIGURE 111. 1. Initial Rates of Iron Release as a Function of the Concentration 
of Cigarette Smoke Solutions and Ferritin Concentration. Panel A show s 
initial rates of iron release from ferritin as a function of the  concentration of 
the different cigarette smoke solutions. Reaction mixtures (final volume 
1 mL) contained ferritin (750 //g) and bathophenanthroline sulfonate (1 mM) 
in 15 mM NaCI, pH 7.4. Reactions were started by addition of different 
volumes of smoke solution prepared by passing the smoke of one cigarette 
per 100 /jL buffer. Whole smoke solution (■); filtered smoke solution (□); 
gas-phase smoke solution (v). Panel B show s the initial rates of iron release 
as a function of the concentration of ferritin. Reaction mixtures contained 
bathophenanthroline sulfonate (1 mM), 100 //I of filtered smoke solution, 
and different am ounts of ferritin.
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increase when SOD is present in the reaction mixture (lines 6 and 9 in Table 
III.I).
The production of hydrogen peroxide by solutions of cigarette smoke 
(20,22) could have an inhibitory effect on the observed rates of iron release. 
Hydrogen peroxide can oxidize Fe(ll) before complexation with 
bathophenanthroline sulfonate (138) but probably not after formation of the 
complex (139,140). In the presence of Fe (II), hydrogen peroxide can also 
oxidize species responsible for iron mobilization such as benzenediols 
present in cigarette smoke solutions. Both of these effects could cause  a 
reduction in the amount of bathophenanthroline-Fe(ll) complex formed. 
Inclusion of catalase in the reaction mixture with gas-phase smoke solution 
does not affect the rate of Fe(ll)-bathophenanthroline complex formation 
(line 2 in Table III.I), while with filtered and whole smoke (lines 5 and 8 in 
Table III.I) it causes about 30%  higher rates. To verify that these  results are 
due to the catalytic activity of the enzymes, BSA w as added to the 
incubation mixtures in concentrations equal to those of catalase and SOD 
and show n to have no effect in the rates of iron release (data not shown).
To investigate the role of oxygen in the rates of iron release, aerobic 
and anaerobic conditions were compared. The effect of oxygen on smoke 
w as also investigated by measuring rates of iron release by filtered-smoke 
solutions incubated for 1 hr at room temperature in air or in argon. Figure 
III.2 show s typical curves obtained in these  experiments with filtered-smoke
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FIGURE III.2. Comparison of the Initial Rates of Iron Released by Filtered 
Smoke in the  Presence and Absence of Air. Time-course formation of 
Fe(ll)-bathophenanthroline disulfonate complex as iron is mobilized from 
ferritin by (1) filtered-smoke solution, release of iron measured under 
anaerobic conditions; (2) filtered-smoke solution incubated in argon for 1 hr, 
release of iron measured under aerobic conditions; and (3) filtered-smoke 
solution incubated in air for 1 hr, release of iron m easured under aerobic 
conditions.
115
solutions. It is apparent from these curves that release of iron is faster in 
the anaerobic system  and that after 1 hr at room temperature, smoke 
solutions incubated in argon release iron at a faster rate than its analogue 
incubated in air. Table III.II summarizes these  results and show s that initial 
rates of iron release with filtered-smoke solutions under complete anaerobic 
conditions (entry 1: buffer and solution in argon) are about 350%  faster than 
in air (entry 3), and also that smoke solutions release iron from ferritin, in the 
presence of air, at rates about 150%  faster when incubated in argon.
HPLC Analysis of Aqueous Solutions of Cigarette Smoke. Cigarette 
smoke is an extremely complex mixture, with thousands of compounds 
isolated and identified. The HPLC chromatogram obtained from a separation 
of filtered smoke solution components is shown in Figure III.3. Catechol and 
hydroquinone were positively identified by spiking the smoke solutions with 
authentic compounds, and also by comparing the UV spectra recorded with 
a diode array detector in chromatograms obtained from smoke solutions and 
from authentic compounds (UV spectra not shown). Figure III.4  show s 
typical HPLC-ECD chromatograms of all three aqueous solutions of cigarette 
smoke obtained with oxidative-electrochemical detection. These traces 
show  that 1,4-dihydroxybenzene (hydroquinone) and 1,2-dihydroxybenzene 
(catechol) are the major electrochemically-active components in the aqueous 
solutions of cigarette smoke under the oxidative conditions used for this
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TABLE 111.II. Effect of Oxygen in the Release of Iron from Ferritin by 
Aqueous Solution of Filtered-Smoke*.
Entry# Anaerobic
System
Smoke
Solution
Incubation
nmol Fe 
Reduced/min 
per mg Ferritin
1 Yes Argon 4 .23  ± 0 . 1 6
2 No Argon 1.79 ±  0 .08
3 No Air 1.18 ±  0 .09
" Reaction mixtures (final volume 1mL) contained ferritin (750 fig),
100 //L of filtered-smoke solution (one cig./100 //L), bathophenanthroline 
sulfonate (1 mM) and catalase (500 units) in 15 mM NaCI, pH 7.4. 
Anaerobic system s were purged with argon and contained glucose oxidase 
(10 units) and glucose (5 mM) in addition to the above components. 
Reactions were initiated by addition of filtered-smoke solutions (incubated 
for 1 hr in either air or argon at room temperature) and absorbance was 
measured continuously at 530  nm during the first 20 min.
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FIGURE III.3 . HPLC Separation of Filtered-Smoke Solution Com ponents 
Detected a t  2 5 4  nm. Separation w as  performed in a Hypersil ODS column 
(200 x 4 .6  mm) with an eluent consisting of w ater and acetonitrile with an 
initial composition of 3%  acetonitrile which w as linearly increased to  50%  
acetonitrile over 12 min at a constan t flow rate of 1 .0  mL/min.
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FIGURE III.4. HPLC with Electrochemical Detection of Aqueous Solutions of 
Cigarette Smoke. ECD-detection w as carried out by applying a voltage of 
+ 3 5 0  mV in the  detection cell, and + 4 0 0  mV in th e  guard cell. Smoke 
solutions w ere  diluted 1 :100  before injection. Whole smoke solution (A), 
filtered sm oke solution (B), and  gas-phase smoke solution (C).
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analysis.
Quantitative analysis of both dihydroxybenzenes in the smoke 
solutions is show n in Table III.III. A comparison of these  results with 
previously reported concentrations of catechol and hydroquinone in cigarette 
smoke condensates is difficult due to differences in the preparation of the 
condensates and the type of cigarettes used. Nanni et al. (75) recently 
reported concentrations of 38 to 58 /j q  for each catechol and hydroquinone 
per cigarette in electrostatic-precipitated condensates using commercially 
available and 1R4F cigarettes. Our determination show s that filtered and 
gas-phase smoke solutions contain concentrations of both 
dihydroxybenzenes below this range, and that hydroquinone is the major 
dihydroxybenzene in whole smoke solution with a concentration of 67 jjq  
per 1R1 cigarette.
Release of Iron from Ferritin by Hydroquinone and Catechol. 
Polyhydroxybenzenes (141,142) and more recently hydroquinone and 
catechol (143) have been show n to release iron from ferritin. Table III.IV 
show s rates of iron release obtained with catechol and hydroquinone under 
aerobic conditions in the presence of either catalase or SOD. Although the 
concentrations used for both benzenediols are equal to those found in whole 
smoke solution by HPLC-ECD (Table III.Ill), initial rates of iron release 
measured for a solution containing both diols (entry 3, Table III.IV) are about
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TABLE lll.lll. Concentrations of Hydroquinone and Catechol in Aqueous 
Solutions of Cigarette Smoke*.
Solution Catechof Hydroquinoneb
MOLARITY
(mM)
//g/cigarette MOLARITY
(mM)
//g/cigarette
Gas-Phase 0 .5 2  ±  0 .0 4 5 .7 6  ±  0 .4 6 0 .1 8  ±  0.01 2.01 ±  0 .1 2
Filtered 1 .2 0  ±  0 .1 0 1 3 .1 6  ±  1 .05 1 .8 6  ±  0.11 2 0 .4 5  ±  1 .23
Whole 3 .0 9  ±  0 .2 5 3 3 .9 7  ±  2 .7 2 6 .1 0  ±  0 .3 7 6 7 .2 0  ±  4 .0 3
a Concentrations were determined by HPLC with electrochemical detection 
applying a constan t voltage of + 3 5 0  mV in the detection cell, and 
+ 4 0 0  mV in the guard cell. Response factors were calculated from 
calibration curves using pure compounds.
b Concentrations of benzenediols in the aqueous solutions (1 cig/100 //L); 
they are expressed as mM (or//grams per cigarette) ±  S.D. (n = 3).
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TABLE III.IV. Aerobic Release of Iron from Ferritin by Benzenediols*.
Entry
no.
Benzenediol Additions nmol Fe Reduced/min 
per mg Ferritin
1 Catechol none 0.50 ± 0.04
2 Hydroquinone none 0.42 ± 0.02
3 Catechol + 
Hydroquinone
none 1.61 ± 0.02
4 Catechol + 
Hydroquinone
Catalase 1.73 ± 0.03
5 Catechol + 
Hydroquinone
SOD 1.76 ± 0.02
6 Whole smokeb none 1.95 ± 0.17
“ Reaction mixtures (final volume 1 mL) contained ferritin (750 /jg), 
bathophenanthroline sulfonate (1 mM), catechol (3.09 mM), hydroquinone 
(6.10 mM), catalase (500 units), and SOD (500 units) in 15 mM NaCI, 
pH 7.4. Reactions were initiated by addition of benzenediols and absorbance 
w as measured continuously at 530  nm during the first 20 min. 
b Contains 3 mM catechol and 6 mM hydroquinone (Table III.III).
1 2 2
17% slower than those  measured with the smoke solution (entry 6, Table 
III.IV). The effects of catalase and SOD (entries 4  and 5, Table III.IV) on 
these  rates are not nearly as dramatic as are the effects of these  enzymes 
on the rates obtained with filtered or whole smoke solutions. Both enzymes 
slightly increase the rates of iron release by a solution containing both 
benzenediols.
Structure of Smoke-Exposed Ferritin. The structure of ferritin after 
incubation with cigarette smoke solutions was studied by three methods: 
iron incorporation, native gel electrophoresis, and amino acid analysis.
Figure III.5 show s the uptake of ferrous iron by smoke-treated ferritin 
samples. After incubation with smoke solutions for 12 hr at 37  °C followed 
by exhaustive dialysis, all three smoke-exposed ferritin preparations exhibit 
rates of ferrous iron uptake comparable to that of the control. The choice of 
buffer in the Fe(ll) uptake assay  is of importance. When ace ta te  buffer is 
used in place of HEPES considerably slower rates of iron incorporation are 
observed (144). Nonetheless, our results indicate that any damage suffered 
by the protein during the incubation with smoke solutions does not change 
its ability to  reincorporate iron compared to  native ferritin (control).
Smoke-exposed ferritin solutions were also subjected to non­
denaturing gel electrophoresis; these  results are show n in Figure III.6.
Ferritin exposed to gas-phase solution (lane 5) does not exhibit a change in 
mobility compared to  native ferritin (lanes 2 ,4, and 6). On the other hand,
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FIGURE III.5. Rates of Iron Uptake by Smoke-Treated Ferritin. Ferritin 
samples were incubated with cigarette smoke solutions for 12 hr at 37 °C, 
and then exhaustively dialyzed before iron incorporation assay. No ferritin 
(v); untreated ferritin control ( •} ;  exposed to gas-phase smoke (O); exposed 
to  filtered smoke (□); exposed to  whole smoke (O) .
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FIGURE III.6. Non-Denaturing Polyacrylamide Gel Electrophoresis of 
Smoke-Treated Ferritin. Typical gels obtained after electrophoresis of ferritin 
sam ples exposed to  different aqueous solutions of cigarette sm oke for 12 hr 
a t  37  °C, with lanes: 1, ferritin exposed to  whole smoke solution; 2 ,4 , and 
6, native ferritin; 3, ferritin exposed to filtered sm oke solution; 5, ferritin 
exposed  to gas-phase  sm oke solution.
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filtered and whole smoke-treated ferritin samples (lanes 3 and 1 respectively) 
exhibit small changes in their mobility compared to the native protein, 
indicative of an increased anionic nature compared to native ferritin.
Table III.V show s the results of amino acid analysis of ferritin samples 
exposed to all three types of smoke solutions. Amino acid analysis obtained 
for native ferritin in this study compares very well with previously published 
amino acid compositions for horse spleen ferritin (145-147). Table III.V 
show s that no significant changes in amino acid composition are detected 
for ferritin exposed to gas-phase solution. However, ferritin exposed to 
filtered and whole smoke solutions show s significant changes in the levels of 
some amino acids. Histidine levels decrease by about 30%  for filtered and 
75%  for whole smoke-treated ferritin. Lysine depletions of about 20 and 
35%  are observed for filtered and whole smoke solutions, respectively. 
Threonine, tyrosine, phenylalanine, and arginine levels decrease by 
approximately 60, 30, 28 and 20% , respectively, in whole smoke-exposed 
samples. On the other hand, levels of glycine, alanine and valine in ferritin 
exposed to  whole smoke solutions increase.
Cigarette smoke solutions produce hydrogen peroxide (20,22,23) 
which could react with ferrous iron released from ferritin to generate an 
activated oxygen species such as the hydroxyl radical or ferryl ion; these 
species could react with the side chains of amino acids in ferritin. The 
amino acid composition of ferritin incubated with whole smoke solution in
127
TABLE III.VI. Amino Acid Composition of Whole Smoke-Exposed Ferritin in 
the Presence of Metal Chelators or Mannitol*.
Residue Control Wholeb Bathophe.c Mannitold
ASX 1 9 .5 ± 2 . 1 1 8 . 6 ± 1 . 8 17 . 7 ± 0 . 2 1 8 .2 ± 0 .1
GLX 2 4 .2  ± 2 . 0 2 5 . 4 ± 2 . 0 3 1 . 5 ± 1 . 5 3 2 . 2 ± 0 . 2
SER 8.1 ± 0 . 6 7 .7  ± 1.8 6 . 7 ± 0 . 0 6.1 ± 0 .1
HIS 5 . 9 ± 0 . 1 1 . 3 ± 0 . 7 4.1 ± 0 .1 3 .3 ± 0 .1
GLY 1 0 . 7 ± 0 . 7 19 . 4 ±  1.5 1 3 . 7 ± 0 . 3 13 . 7 ± 0 . 0
THR 5.1 ± 0 . 3 2 . 0 ± 0 . 5 4 . 4 ± 0 . 0 4 .7  ± 0 . 0
ALA 15.1 ± 0 . 4 1 8 . 3 ± 0 . 2 17.1 ± 0 .1 17 .7  ± 0 . 0
ARG 10.1 ± 0 . 5 8 . 0 ± 0 . 4 7 .3 ± 0 .1 7 . 5 ± 0 . 2
TYR 5 . 0 ± 0 . 5 3 . 5 ± 0 . 2 5 .4 ± 0 .1 4 . 3 ± 0 . 1
VAL 7 . 8 ± 0 . 7 9 . 2 ± 0 . 5 9 . 8 ± 0 . 2 9 .4 ± 0 .1
MET 3 . 0 ± 0 . 2 2 . 9 ± 0 . 5 3.1 ± 0 . 3 3.1 ± 0 . 0
METSO 0 .0 0 .0 0 .0 0 .0
ILE 3 . 8 ± 0 . 3 3 . 9 ± 0 . 7 5 . 6 ± 0 . 3 4 .3  ± 0 . 0
PHE 7 . 4 ± 0 . 4 5 . 3 ± 0 . 5 6 .9 ± 0 . 1 7 . 0 ± 0 . 0
LEU 2 7 .5  ± 0 . 7 2 8 . 5 ± 0 . 8 25.1 ± 0 .1 25.1 ± 0 .1
LYS 9 . 2 ± 0 . 7 6.1 ± 0 . 5 6 .5 ± 0 .1 6.1 ± 0 .1
“ Amino acid composition is given as number of residues per subunit of
2 2 ,5 0 0  D. Results are expressed as the mean ±  standard deviation (n = 5). 
b Ferritin samples (750 //g) were incubated with whole smoke solutions 
(100 //L) in 100 mM phosphate buffer for 12 hr at 37 °C (from Table III.V). 
c In the presence of 1 mM bathophenanthroline sulfonate. 
d In the presence of 1 mM mannitol.
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TABLE 111 .Vi. Amino Acid Composition of Whole Smoke-Exposed Ferritin in 
the Presence of Metal Chelators or Mannitol”.
Residue Control Wholeb Bathophe.0 Mannitold
AS X 1 9 .5 ± 2 .1 1 8 . 6 ±  1 .8 1 7 . 7 ± 0 . 2 1 8 .2 ± 0 .1
GLX 2 4 .2  ± 2 . 0 2 5 .4  ± 2 . 0 3 1 . 5 ± 1 . 5 3 2 . 2 ± 0 . 2
SER 8.1 ± 0 . 6 7 .7  ± 1.8 6 . 7 ± 0 . 0 6.1 ± 0 .1
HIS 5 .9 ± 0 .1 1 . 3 ± 0 . 7 4.1 ± 0 .1 3 . 3 ± 0 . 1
GLY 1 0 . 7 ± 0 . 7 1 9 . 4 ±  1.5 13 . 7 ± 0 . 3 1 3 . 7 ± 0 . 0
THR 5.1 ± 0 . 3 2 . 0 ± 0 . 5 4 .4  ± 0 . 0 4 .7  ± 0 . 0
ALA 15.1 ± 0 . 4 1 8 . 3 ± 0 . 2 17.1 ± 0 .1 17 . 7 ± 0 . 0
ARG 10.1 ± 0 . 5 8 . 0 ± 0 . 4 7 .3 ± 0 .1 7 . 5 ± 0 . 2
TYR 5 . 0 ± 0 . 5 3 . 5 ± 0 . 2 5 .4 ± 0 . 1 4 . 3 ± 0 . 1
VAL 7 . 8 ± 0 . 7 9 .2  ±  0 .5 9 . 8 ± 0 . 2 9 . 4 ± 0 . 1
MET 3 . 0 ± 0 . 2 2 . 9 ± 0 . 5 3.1 ± 0 . 3 3.1 ± 0 . 0
METSO 0 .0 0 .0 0 .0 0 .0
ILE 3 . 8 ± 0 . 3 3 . 9 ± 0 . 7 5 . 6 ± 0 . 3 4 . 3 ± 0 . 0
PHE 7 . 4 ± 0 . 4 5 . 3 ± 0 . 5 6 .9 ± 0 .1 7 . 0 ± 0 . 0
LEU 27 .5  ± 0 . 7 2 8 . 5 ± 0 . 8 25.1 ± 0 .1 25.1 ± 0 .1
LYS 9 . 2 ± 0 . 7 6.1 ± 0 . 5 6 .5 ± 0 .1 6.1 ± 0 .1
“ Amino acid composition is given as number of residues per subunit of
22 ,5 0 0  D. Results are expressed as the mean ±  standard deviation (n = 5). 
b Ferritin samples (750 jjg) were incubated with whole smoke solutions 
(100 //L) in 100 mM phosphate buffer for 12 hr at 37 °C (from Table III.V). 
0 In the  presence of 1 mM bathophenanthroline sulfonate. 
d In the  presence of 1 mM mannitol.
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the presence of bathophenanthroline sulfonate or the hydroxyl radical 
scavenger mannitol was studied in an effort to determine the origin of the 
damage to the protein; these  results are show n in Table III.VI. Both 
bathophenanthroline and mannitol give similar results; they afford almost 
complete protection to  threonyl, tyrosyl, and phenylalanyl residues.
Histidine is partially protected (ca. 61 %)9 by bathophenanthroline and less 
efficiently by mannitol (ca. 43% ). Lysine and arginine depletions are not 
prevented by the metal chelator or by mannitol. Alanine and valine levels 
remain higher than in the control in the  presence of bathophenanathroline 
sulfonate or mannitol, while levels of glycine are increased by 30%  
compared to an increase of 80%  in the absence of bathophenanthroline or 
mannitol. No significant methionine oxidation w as detected in either the 
presence or absence of bathophenanthroline sulfonate or mannitol.
DISCUSSION
The data presented above demonstrate that aqueous solutions of 
cigarette smoke are capable of reducing and mobilizing iron from ferritin.
Two possible mechanisms for this release are : reduction of ferritin iron by 
superoxide ion generated during the autoxidation of polyhydroxybenzenes
9 Percent protection is defined as 100 times the difference: 
100-[(control -experiment with additive)/(control -smoke experiment)].
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present in smoke solutions (1,23); or direct reduction of iron by smoke 
components. Our data on the  effect of SOD suggest tha t the second 
mechanism is more likely.
Superoxide ion and hydrogen peroxide are formed in aqueous far 
solutions of cigarette smoke from the autoxidation of smoke com ponents 
(22,23). The results obtained here with SOD indicate tha t superoxide ion, 
which is known to release iron from ferritin (138,148), does not contribute 
significantly to the release of iron caused by cigarette smoke. In fact, SOD 
enhances the rate of formation of the Fe(ll)-bathophenthroline complex in the 
presence of filtered and whole smoke, and has no effect with gas-phase 
smoke solutions. Addition of catalase gives similar results, enhancing rates 
of Fe(ll) complex formation with filtered and whole smoke solutions but 
showing no effect in the presence of gas-phase smoke. The effects of these 
tw o enzym es indicate that superoxide ion and hydrogen peroxide formation 
is only relevant in filtered and whole smoke preparations, and that both 
species inhibit the rate of formation of the Fe(ll)-bathophenanthroline 
complex. The effect of catalase is most probably due to preventing the 
oxidation of Fe(ll) released from ferritin by hydrogen peroxide and 
consequently causing an increased recovery of reduced iron by 
bathophenanthroline (138). The effect of SOD is discussed below.
Analysis by HPLC using electrochemical detection show s the presence 
of hydroquinone and catechol in all our smoke solutions, along with other
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unidentified minor com ponents (Figure III.4). Recently Leanderson and 
Tagesson (29) also detected hydroquinone and catechol, using HPLC-ECD 
under oxidative conditions, as the major electrochemically-active 
com ponents in aqueous solutions of cigarette smoke.
The concentration of these  phenols increases as the smoke is 
subjected to less filtration and the sum of their amounts in all smoke 
solutions correlates with the rates of iron release (see Figure III.7). The 
difference in concentration of phenols in filtered and non-filtered smoke 
solutions could in part explain the  differing rates of iron release observed. 
Although these  benzenediols are abundant in cigarette smoke (75) and they 
are probably important contributors in the reduction of ferritin, our data do 
not allow us to discard other smoke components also intervening in the 
observed release of iron. For example, cigarette smoke contains high 
concentrations of nitric oxide which has been shown to release iron from 
ferritin (149). Our results also suggest that cigarette smoke is a much more 
complex system  than a mixture of hydroquinone and catechol. The rates of 
iron release measured with a mixture of both benzenediols, in concentrations 
comparable to those determined in whole smoke, are not increased by 
catalase and SOD as much as with the smoke solutions (Table III.IV).
Protein Damage. Amino acid analysis (Tables III.V and III.VI) along 
with the results obtained from native gel electrophoresis indicate that both 
filtered and whole smoke solutions are capable of changing the chemical
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FIGURE III.7: Initial Rates of Iron Release as a Function of the Combined 
Concentrations of Hydroquinone and Catechol Found in the Three Different 
Solutions of Cigarette Smoke. Abscissa values obtained from Table III.I, 
ordinate values obtained from Table III.II (R2= 0.992). A: gas-phase smoke 
solution; B: filtered-smoke solution; C: whole-smoke solution.
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composition of ferritin. These modifications, however, do not seem  to 
undermine the  ability of ferritin to reincorporate iron. The changes in the 
levels of histidine, lysine, and arginine for both filtered- and whole smoke- 
exposed ferritin samples could explain the changed electrophoretic mobilities 
observed for these  tw o treated ferritin samples in native gels. Modification 
of these  basic amino acids could result in a net decrease in positive charge, 
making the protein more anionic than untreated ferritin. Damage to  lysine, 
arginine and about 30%  of total histidine is not protected by either 
bathophenanthroline or mannitol, indicating tha t not all amino acid damage 
involves ferrous iron or an active oxygen species. These results suggest 
that cigarette smoke com ponents react with histidyl, arginyl and lysyl 
residues in ferritin. We have previously observed depletions of lysyl and 
histidyl residues in a -1-proteinase inhibitor after incubation with cigarette 
smoke aqueous solutions10. Also, the formation of cyanomethyl 
derivatives of lysyl and arginyl residues upon reaction with cigarette smoke 
has been reported (72). The lack of methionine oxidation by smoke 
solutions even in the absence of bathophenanthroline or mannitol is 
unexpected, but our present data do not allow us to afford a proper 
explanation for this observation.
The reductive release of iron from ferritin has been well documented
10 See Tables I.II and I.IV in Chapter I.
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to cause  oxidative damage, principally by initiating lipid peroxidation 
(138 ,1 41 ,142 ,150 ,151). We suggest tha t release of iron from ferritin 
caused by solutions of cigarette smoke in the presence of hydrogen 
peroxide, also produced by smoke solutions, could also catalyze the 
oxidation of proteins.
The Effect of SOD. The release of iron is faster under argon than 
under air, and filtered-smoke solutions release iron faster when incubated in 
argon than when incubated in air. It w as also observed tha t filtered and 
whole smoke solutions release iron from ferritin more efficiently when SOD 
is added to incubation mixture. This suggests  that under aerobic conditions 
autoxidation of species responsible for the release of iron from ferritin occurs 
with the effect of diminishing the reducing capability of the smoke solutions, 
and that SOD prolongs the life of these  reducing species. Oxygen uptake 
experiments with smoke solutions and ferritin (data not shown) suggest that 
SOD and catalase inhibit initial rates of oxygen consumption of both filtered 
and whole smoke solutions, confirming this hypothesis.
A possible mechanism for the release of iron from ferritin by cigarette 
smoke solutions which could explain the effect of SOD is show n in eqs 1 
through 6. In eq 1, hydroquinone and catechol (QH2), along with other 
electrochemically-active compounds present in lower concentrations in 
cigarette smoke solutions, are proposed to  be the major contributors in the 
release of iron from ferritin. Nitric oxide is probably not a major contributor
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in the release of iron since solutions purged with argon, which are not likely 
to  contain high concentra tions of this gas, release iron from ferritin m ost 
efficiently. A contribution to the release of iron from semiquinones (Q H ), 
generated in eqs 1 and 4, cannot be eliminated by the data presented  here. 
Semiquinones have been show n to  release iron effectively from ferritin 
principally under anaerobic or hypoxic conditions (152). However, Monteiro 
et al. (153) observed that benzosemiquinone does not cause  the  release of 
iron under aerobic conditions, and that oxygen causes  a marked inhibition in 
iron release by other semiquinones. Other studies (142,151) have show n 
enhancem ent of iron release from ferritin in the  presence of SOD using 
dialuric acid, acid-hydrolyzed divicine and 6-hydroxydopamine as reducing 
species, and a rationale similar to that proposed here w as given.
QH2 + Fe (III) ----> QH* + Fe (II) + H+ (1)
QH* + Fe(III) --------> Fe (II) + Q + H+ (2)
QH* + 02 --- -------- Q + 02* + H+ (3)
QH2 + 02* + H+ --------> QH* + H202 (4)
QH* + 02t + H* --------> Q + H202 (5)
2 QH* QH2 + Q (6)
CONCLUSION
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Our in vitro observations indicate that cigarette smoke releases iron 
from ferritin and that this release is accompanied by damage of the protein 
which is prevented in part by a metal chelator and a hydroxyl radical 
scavenger. Iron is known to  catalyze the  formation of reactive oxygen 
species (58) which have been implicated in a variety of deleterious oxidative 
processes (59). We suggest the release of iron from ferritin by cigarette 
smoke may alter iron metabolism in the lungs of smokers. Also, cigarette 
smoke in the presence of biological forms of iron could constitute an 
oxidation system  capable of causing oxidative damage to proteins. These 
findings provide possible explanations for the observed inflammation of the 
lower respiratory tract and increased concentrations of iron found in PAM of 
tobacco  users.
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